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Abstract 
 
Myostatin is a negative regulator of muscle growth. When it is not present or non-
functional double-muscling occurs, the primary characteristic of this phenotype being 
an increase in muscle mass. Another characteristic of double-muscling is an increased 
proportion of type IIB muscle fibres, which rely on glycolysis as their primary energy 
source, as opposed to type IIA and type I fibres which rely on oxidative 
phosphorylation. This switch in muscle metabolism directly impacts on the 
mitochondria, as mitochondria from glycolytic muscle fibres have been shown to 
have differences in metabolic activity. The increased proportion of glycolytic muscle 
fibres present in myostatin knockout animals provides a unique model to investigate 
alterations in muscle fibre type metabolism.  
 
The mouse model of myostatin knockout utilised during this study was generated by 
genetic deletion of exon three of the myostatin gene. Verification of this knockout 
was attempted by western blot analysis, but only the latency associated protein (LAP) 
was detected. Interestingly, the LAP was barely detectable in the knockout muscle 
suggesting deletion of exon three affects binding of anti-myostatin antibodies to the 
LAP, as that part of the gene is not deleted.  
 
A comparison of the basal mitochondrial stress levels was made, also by western blot 
analysis. The knockout mitochondria showed no change in levels of heat shock 
protein 60 or superoxide dismutase 2, indicating that they are not being subjected to 
any increased stress due to the myostatin knockout phenotype.  
 i
 A comparative proteomics approach was used to detect changes in the mitochondrial 
proteome of myostatin knockout gastrocnemius muscle to gain clues to how 
mitochondria from glycolytic muscle fibres differ from those present in oxidative 
fibres. This was undertaken using two-dimensional electrophoresis (2-DE), in-gel 
tryptic digests and peptide mass fingerprinting by mass spectrometry. A 2-DE gel 
protein loading of 220µg was shown to give the best protein spot resolution and the 
most crucial step in the loading process was found to be the laying of the 
immobilized pH gradient, which had to be performed very carefully to obtain a 
consistent loading pattern. This study resolved only around 160 protein spots out of 
the estimated 1,000 to 2,000 proteins present in the mitochondria. Modulation of six 
proteins was seen at a p<0.1 level, but were unable to be identified using the current 
methodology. More abundant mitochondrial proteins were able to be identified, but 
showed no significant modulation. Malate dehydrogenase and 3-hydroxyacyl-CoA 
dehydrogenase, which were identified during this study, have been reported to have 
decreased activity in mitochondria from glycolytic muscle fibres. This study suggests 
that the change in activity observed by other researchers is due to inhibition of these 
enzymes in the glycolytic fibres or activation in the oxidative fibres. 
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Chapter 1 - Introduction and Literature Review 
CHAPTER ONE 
Introduction and Literature Review 
 
The following review will cover the biology of myostatin, and the effect its removal 
has on animals, focusing in on the metabolic consequences of the myostatin knockout 
phenotype and how comparative proteomics can and has been used to investigate 
differences in mitochondrial metabolic processes. 
 
1.1 Myostatin 
Myostatin, which is also known as growth and differentiation factor (GDF)-8, is a 
secreted protein which is predominantly expressed in skeletal muscle, and negatively 
regulates muscle growth by altering transcriptional activity through the activin type II 
receptor.  
 
1.1.1 Characteristics of myostatin 
The full length myostatin protein consists of a hydrophobic signal sequence for 
secretion at the amino terminal (N-terminal), followed by what is called the latency 
associated protein (LAP) and a small mature region at the carboxyl terminal. The 
pattern of cysteine residues in the mature region of the protein is highly conserved 
and forms a cysteine knot when the protein homodimerises (McPherron et al., 1997). 
These are the common characteristics of the transforming growth factor beta (TGF-β) 
superfamily, of which myostatin is a member (McPherron et al., 1997). 
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Myostatin is synthesized as a 52kDa precursor molecule (Thomas et al., 2000) which 
dimerises with another myostatin molecule by the formation of disulfide bonds in the 
LAP and the mature region (McPherron et al., 1997). This inactive form of myostatin 
is secreted into the systemic circulation, where it is proteolytically processed by bone 
morphogenetic protein-1/tolloid metalloproteinases (Wolfman et al., 2003; Scott et 
al., 1999) at a highly conserved Arg-Ser-Arg-Arg (R-S-R-R) cleavage site (Thomas 
et al., 2000). The 40kDa LAP portion of the protein is cleaved from the 12kDa 
mature region, releasing the 24kDa active myostatin dimmer, which is responsible for 
inhibition of skeletal muscle growth, see Figure 1.1 A. 
 
Myostatin is present in all vertebrates, and shows a high degree of homology between 
a broad spectrum of animals. McPherron and Lee (1997) compared the amino acid 
sequence for myostatin from murine, rat, human, baboon, bovine, porcine, ovine, 
chicken, turkey and zebrafish. All sequences had a punitive secretion signal sequence 
at the N-terminus, and a proteolytic cleavage site between amino acid 263 and 266. 
Most of these followed the sequence R-S-R-R except for the zebra fish myostatin. All 
the animals contained identical spacing of the cysteine residues in the mature region 
of the protein and six of the ten animals investigated had identical mature regions. 
 
1.1.2 Myostatin signalling 
Myostatin exerts its effect on muscle cells by binding to the activin type IIB receptor 
(Act RIIB) on the outside of the cell (Lee and McPherron, 2001). Act RIIB and the 
type I receptor are trans-membrane serine-threonine (Ser-Thr) receptor kinases with 
 2
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Figure 1.1 The processing of myostatin and its role as a signaling molecule. 
(A) Mature myostatin is cleaved from the LAP by metallo proteinaises. (B) It can 
then bind to the activin type IIB receptor, which auto-phosphorylates itself. The 
activin type I receptor is recruited to the complex and its GS domain is 
phosphorylated by the type II receptor. (C) The type I receptor then phosphorylates 
Smad2 and Smad3 which form heterodimers with a Smad4. (D) This can then 
translocate the nuclear membrane and alter transcription rates, Smad3 also interacts 
directly with MyoD to inhibit its action. 
 3
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cysteine-rich extracellular domains, a membrane spanning domain, and an 
intracellular Ser-Thr kinase domain. The type I receptor differs from the type II 
receptor by having a serine-glycine repeat, just before the intracellular Ser-Thr kinase 
domain, this is termed the GS domain (Shi and Massague, 2003).  
 
The two receptor molecules usually exist as monomers in the cell membrane, but 
when a ligand binds to the type II receptor, the type I receptor is sequestered to the 
complex. Upon binding the ligand, the type II receptor phosphorylates itself and the 
GS domain of the type I receptor, activating its Ser-Thr kinase domain (Shi and 
Massague, 2003), as shown in Figure 1.1 B. 
 
The activated type I receptor goes on to phosphorylate Smad2 and Smad3 in the 
cytoplasm of the cell (Shi and Massague, 2003). Once phosphorylated, these Smads 
form heterodimers with Smad 4 and this complex is then able to translocate the 
nuclear membrane and exert transcriptional control (Shi and Massague, 2003). See 
Figure 1.1 C.  
 
Smad3 and Smad4 have both been shown to interact directly with DNA at Smad 
binding elements, which consist of a palindromic (GTCTAGAC) sequence, present in 
the promoter regions of many TGF-β sensitive genes (Dennler et al., 1998; Derynck 
et al., 1998; Zawel et al., 1998). Binding of the Smad complex to these promoter 
regions up-regulates and down-regulates an array of genes involved in muscle growth 
and differentiation, see Figure 1.1 D. 
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1.1.3 Physiological action of myostatin 
Myostatin inhibits myoblast proliferation by up-regulating the cyclin-dependent 
kinase (Cdk) inhibitor, p21, and at the same time down-regulating expression of 
Cdk2. The resulting reduction in Cdk2 activity, from p21 induced inhibition and 
reduced levels, results in the retinoblastoma protein becoming hypo-phosphorylated. 
This results in the cell cycle being arrested in G1 phase (Joulia et al., 2003; 
McCroskery et al., 2003; Rios et al., 2001).  
 
Myostatin also inhibits myoblast differentiation by down-regulating muscle 
regulatory factors (MRFs): MyoD, Myf-5 and myogenin. MRF levels are modulated 
by both over-expression of myostatin (Joulia et al., 2003), and genetic deletion of the 
protein coding sequence (McCroskery et al., 2003; Langley et al., 2002). Smad 3 also 
inhibits MyoD directly by interfering with the formation of the active MyoD·E 
protein complex (Liu et al., 2001). 
 
Myostatin acts as a chalone, a term coined by Bullough in 1962 to describe a secreted 
molecule which acts upon itself to inhibit various cellular functions. In the case of 
myostatin, to inhibit growth of the muscle cells it is produced by. When myostatin is 
not functional, or is not present, there is increased myoblast proliferation and 
differentiation. The result of this in an increase in muscle mass due to an increase in 
the number of muscle fibres (hyperplasia), and/or in the size of the individual muscle 
fibres (hypertrophy) (McCroskery et al., 2003). This phenomenon is called double-
muscling, and will be discussed in greater detail in section 1.2. 
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1.1.4 Expression of myostatin 
Myostatin is expressed early on during embryogenesis (Amthor et al., 2002; 
McPherron et al., 1997) and continues to be expressed right into adulthood 
(Kambadur et al., 1997; McPherron et al., 1997). It is predominantly expressed in 
skeletal muscle (Potts et al., 2003; Jeanplong et al., 2001; Oldham et al., 2001; Bass 
et al., 1999; Carlson et al., 1999; Kocamis et al., 1999; Sharma et al., 1999; Ji et al., 
1998; Kambadur et al., 1997; McPherron et al., 1997), but has also been detected at 
much lower levels in other muscles and tissues (Sharma et al., 1999; Ji et al., 1998; 
McPherron et al., 1997). 
 
Within skeletal muscle, myostatin is further restricted to certain muscle fibre types. 
Myostatin is expressed in higher amounts in the type II fibres (fast twitch) than it is in 
type I fibres (slow twitch) (Carlson et al., 1999). The consequence of this unique 
pattern of expression, when functional myostatin is lost, will be discussed further in 
section 1.2.1. 
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1.2 Double-muscling 
The double muscling phenomenon was first documented by Culley (1807). It occurs 
naturally in several cattle breeds, the most well characterised being the Belgian Blue 
and Piedmontese breeds. Recently, many different methods of inducing double 
muscling in animals, through myostatin knockout, have been used. 
 
1.2.1 Characteristics of the double-muscling phenotype 
The primary characteristic of the double-muscling phenotype is an increase in muscle 
mass and a decrease in fat deposition (McPherron et al., 1997). The double-muscling 
phenotype is also characterised by reduced connective tissue, a lower proportion of 
bone, and a reduction in size of organs such as the heart, lungs and liver (Boccard, 
1981). Double-muscled cattle are also more susceptible to stress and heat. They have 
a reduced capacity to dissipate the extra heat generated by their increased muscle 
mass, due to a reduced respiratory capacity, less body surface per mass unit and 
poorer circulation. The animals also fatigue faster than normal animals because of 
increased metabolic acidosis caused by lower aerobic muscle metabolism (Boccard, 
1981) and reduced blood circulation (Menissier, 1982) to remove the lactate 
produced. 
 
Double-muscled animals also have an altered fibre type composition. In the double-
muscled tissue there is a larger proportion of type II fibres, and a reduction in the 
number of type I fibres. There is also an increased amount of type IIB fibres 
(glycolytic) compared to type IIA fibres (oxidative) (Girgenrath et al., 2005). A 
transition from type IIA fibres to type IIB fibres naturally occurs as animals age, but 
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this effect is more exaggerated in animals which lack functional myostatin (Wegner 
et al., 2000), presumably due to the increased level of type II fibres present in the 
animals. This has been coined the ‘glycolytic switch’ and in mice occurs within six 
weeks of birth (personal communication with Ravi Kambadur).  
 
1.2.2 Genetic deletion of mature myostatin 
Myostatin was discovered in 1997 by McPherron et al., when they replaced the 
mature region of myostatin with a neomycin cassette. This resulted in a 10.4kb 
transcript which lacked the functional region of myostatin (the mature region), 
instead of the 11.2kb transcript seen in wild type mice. This genetic deletion of 
myostatin resulted in double-muscling due to both hyperplasia and hypertrophy. 
Skeletal muscle samples used in this study were obtained from myostatin knockout 
mice generated from the above genetic deletion. 
 
There are many other methods of inducing double-muscling in animals through 
myostatin knockout. These are summarised in Table 1.1. It is notable to point out that 
the mutations which occur in the myostatin gene from Belgian Blue and Piedmontese 
cattle were naturally occurring mutations which have subsequently been selected for 
by the meat industry (Bellinge et al., 2005). 
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Table 1.1 Methods of myostatin knockout 
Methods of myostatin knockout that have been shown to induce double-muscling in 
animals and the characteristics that each of these models display. 
 
Method of myostain 
knockout 
Animal used 
in model 
Characteristics of model Reference 
 Deletion of 
nucleotides 821-831 
 Belgian 
Blue cattle 
 Frame shift and 
premature termination. 
 Hyperplasia. 
 Increase in glycolytic 
fibres. 
Grobert et al., 1997; 
Kambadur et al., 
1997; 
McPherron and Lee, 
1997 
    
 G to A transition at 
amino acid 314 
 Piedmontese 
cattle 
 Mice 
 Cysteine knot cannot 
form. 
 Hyperplasia. 
 Increase in glycolytic 
fibres. 
Berry et al., 2002; 
Nishi et al., 2002; 
Grobert et al., 1997; 
Kambadur et al., 
1997; 
McPherron and Lee, 
1997 
    
 Deletion of exon 3.  Mice  Hyperplasia and 
hypertrophy. 
 Increase in glycolytic 
fibres. 
McPherron et al., 
1997 
    
 Over-expression of 
follistatin 
 Mice  Antagonises myostatin. 
 Hyperplasia and 
hypertrophy 
Lee and McPherron 
et al., 2001 
    
 Over-expression of 
the LAP 
 Mice  Antagonises myostatin. 
 Hyperplasia and 
hypertrophy 
Lee and McPherron 
et al., 2001 
    
 Postnatal genetic 
deletion of exon 3 
by cre-loxP. 
 Mice  Exon 3 not transcribed 
when cre-recombinase is 
expressed. 
 Hypertrophy and minute 
hyperplasia. 
Grobert et al., 2003 
    
 Postnatal 
administration of 
anti-myostatin 
antibodies. 
 Mice  Antagonises myostatin. 
 Hypertrophy. 
 No change in 
metabolism. 
Girgenrath et al., 
2005; 
Whittmore et al., 
2003 
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1.3 How do muscle cells obtain ATP from metabolic processes? 
Cellular metabolism is based around three central pathways, which break down 
substrates to form ATP: glycolysis, the tricarboxylic acid (TCA) cycle and oxidative 
phosphorylation. The three different processes are localised within the cell, with 
glycolysis occurring in the cytoplasm, the TCA cycle in the matrix of the 
mitochondria and oxidative phosphorylation in the mitochondrial inner membrane. 
The different muscle fibre types discussed thus far, type I, type IIA, and type IIB, are 
characterised firstly on their twitch speed and then by how they obtain their energy, 
whether primarily from glycolytic processes or oxidative phosphorylation. 
 
1.3.1 Glycolysis 
Glycolysis is observed in all organisms. Glucose is broken down in a series of ten 
reactions to yield two pyruvate molecules, two ATP and two NADH. Different sugars 
can be fed into glycolysis at various stages and larger sugars and carbohydrates can 
be broken down to be utilised as a substrate. 
 
The first phase of glycolysis involves priming of the glucose by phosphorylating it 
twice. The D-fructose-1,6-bisphosphate formed is cleaved into two three carbon 
sugars, which go on to produce four ATP via substrate-level phosphorylation, two 
NADH and two molecules of pyruvate in the second phase of glycolysis. For 
glycolysis to continue functioning, the NADH produced in this reaction must be re-
oxidised to NAD+. In animals, this can occur through the electron transport system in 
the mitochondria, but not under anaerobic conditions, such as rapidly contracting 
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muscles. In this situation the pyruvate produced in glycolysis is reduced to lactate, re-
oxidising NADH to NAD+ (Garrett and Grisham, 1999). 
 
1.3.2 Tricarboxylic acid cycle 
The TCA cycle can feed on more substrates than just pyruvate. Amino acids, glycerol 
and fatty acids can also be oxidised in the TCA cycle, and the reducing potential 
produced used to make ATP. 
 
Carbon can enter the TCA cycle at many different locations, but primarily enters as 
acetyl-CoA which is transferred to oxaloacetate by citrate Synthase. The acetyl-CoA 
can be produced from pyruvate, being fed into the TCA cycle through the pyruvate 
dehydrogenase complex, or by β-oxidation of fatty acids. The citrate produced in this 
reaction goes through a series of eight reactions, removing two CO2 molecules, and 
producing one ATP via substrate-level phosphorylation, one FADH2 and three 
NADH, in addition to the molecule produced by pyruvate dehydrogenase. This series 
of reactions results in oxaloacetate being formed to act as the carrier in the next cycle 
(Garrett and Grisham, 1999). 
 
1.3.3 Oxidative phosphorylation 
Although glycolysis and the TCA cycle produce four ATP by oxidising a single 
molecule of glucose to carbon dioxide, most of the energy is retained in the reducing 
potential stored in the molecules of NADH and FADH2 which were produced. This 
energy is converted into ATP by oxidative phosphorylation, utilising the electron 
transport system (ETS) and ATP synthase enzyme complex embedded in the 
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mitochondrial inner membrane. The NADH is used to reduce coenzymes of the 
respiratory chain and the FADH2 to reduce the flavoproteins. The electron gained 
from this reduction is passed down from one component of the ETS to the next, due 
to an increase in the reduction potential of each component. As the electrons move 
through each of the ETS components, their reduction potential gradually approaches 
that of O2/H2O, until they reach cytochrome c oxidase (COX), the terminal electron 
acceptor. It is here that the electrons are passed onto oxygen and hydrogen, forming 
water. 
 
The proton from the coenzyme/flavoprotein reduction mentioned before is pushed 
into the inter-membrane space of the mitochondria, eventually building up a proton 
gradient. The energy stored in this chemiosmotic gradient is converted into the high 
energy phosphate bond in ATP by ATP synthase. This protein complex, made up of 
approximately 24 subunits, acts as a motor and turns as protons flow through its F0 
complex. This drives the conformational changes in the F1 complex required to 
synthesise ATP. 
 
Utilising oxidative phosphorylation to fully oxidise the glucose molecule introduced 
into glycolysis results in approximately 15 times more ATP being produced than with 
glycolysis. It also provides for the re-oxidation of NADH to NAD+ in aerobic 
situations, without lactic acid buildup. But oxidative phosphorylation cannot operate 
in an anaerobic environment, and is a slower method of energy production than 
glycolysis (Garrett and Grisham, 1999). 
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1.3.4 Muscle fibre type differences in cellular metabolism 
General differences seen between type I and type II fibres are that type I have more 
mitochondria (Schmidt and Herpin, 1997; Jackman and Willis, 1996) and higher 
myoglobin content (Donoghue et al., 2005; Kim et al., 2004). This is due to the Type 
I fibres relying on oxidative phosphorylation for their ATP supply. Type IIB fibres 
rely primarily on glycolysis for energy production and have increased expression of 
glycolytic enzymes to support this (Hallauer and Hastings, 2002; Rivero et al., 1998). 
Even though Type IIA fibres are fast twitch fibres, they rely on oxidative 
phosphorylation for their energy and have been described as having a more similar 
mitochondrial profile to type I fibres, than to type IIB fibres (Gueguen et al., 2005A). 
Because of this, muscle fibres discussed from herein will refer to their method of 
energy metabolism, oxidative or glycolytic, and not their twitch speed. 
  
Oxidative and glycolytic fibre mitochondria do not show any difference in ATP 
synthase activity, but oxidative fibre mitochondria do show a greater rate of ATP 
synthesis (Gueguen et al., 2005B). This was postulated to be due to the increased 
COX activity seen in mitochondria from oxidative fibres (Gueguen et al., 2005B; 
Schmidt and Herpin, 1997; Jackman and Willis, 1996). Mitochondrial respiration 
studies, using mitochondria isolated from oxidative and glycolytic fibres, report high 
respiratory control ratios, between 4 and 19, indicating well coupled mitochondria 
(Gueguen et al., 2005B; Mogensen and Sahlin, 2005; Schmidt and Herpin, 1997). 
Basal respiration (state IV respiration) in mitochondria isolated from oxidative and 
glycolytic fibres is the same (Gueguen et al., 2005B; Mogensen and Sahlin, 2005), 
but ADP stimulated respiration (state III respiration) differs. Compared to utilization 
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of a fatty acid substrate mitochondria from both oxidative and glycolytic fibres 
respire well of pyruvate. But there is deliberation as to whether glycolytic or 
oxidative fibres have a higher respiration rate. Both Gueguen et al. (2005B) and 
Jackman and Willis (1996) have reported it higher in oxidative fibres, whilst 
Mogensen and Sahlin (2005) report conflicting results. But respiration rates of 
glycolytic fibre mitochondria fed on the fatty acid, palmitoyl-L-carnitine drop 
dramatically. State III respiration on this substrate was 58% of that seen on pyruvate 
in the glycolytic fibre mitochondria, whilst oxidative fibre mitochondria maintained 
95% of their respiratory activity (Mogensen and Sahlin, 2005). This supports the 
higher COX activity observed in oxidative fibres (Gueguen et al., 2005B; Schmidt 
and Herpin, 1997; Jackman and Willis, 1996) and their increased capacity for fatty 
acid metabolism (reviewed in Cortright et al., 1997). 
 
Mitochondria from oxidative fibres have also been shown to have a lower sensitivity 
to ADP than those from glycolytic fibres (Gueguen et al., 2005A; Willis and 
Jackman, 1995). Mogensen and Sahlin (2005) found that glycolytic mitochondria had 
a higher affinity for ADP when feeding on palmitoyl-L-carnitine. They suggested that 
this would be advantageous for the animal as it would divert metabolism to the 
mitochondria and fatty acid metabolism during times of basal respiration, when ATP 
and oxygen concentrations were high. This would conserve carbohydrate stores for 
times of exertion when glycolytic metabolism was utilised. However, these studies 
were performed in the presence of ATP consuming enzymes, Gueguen et al. (2005B) 
later showed the mitochondria’s affinity for ADP is inhibited by the presence of ATP. 
This ATP inhibition was more pronounced in mitochondria from glycolytic fibres 
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though, supporting the data showing an increased affinity for ADP in glycolytic fibre 
mitochondria. The mechanism for this ATP mediated inhibition is still to be 
elucidated, but it is theorised that the ATP could compete with ADP for binding of 
the adenine nucleotide translocase (ANT) and subsequent transport across the 
mitochondrial membrane. Interestingly, at basal ATP levels in muscle, 5-8mM, this 
ATP inhibition could be occurring. This suggests that mitochondrial activity in 
glycolytic fibres could be more important during the recovery phase after rapid 
muscle contraction, than during basal respiration. 
 
This shows that there is still deliberation about the function of mitochondria present 
in the glycolytic muscle fibres. And it still remains to be elucidated, how the changes 
which have been observed are actually occurring. 
 
1.3.5 Metabolism in double-muscled animals 
McPherron and Lee (2002) investigated the metabolism of myostatin knockout mice, 
compared to wild type mice to determine whether the decreased fat accumulation 
seen in the knockout mice was due to increased oxidative metabolism. They found a 
decreased metabolic rate compared to the wild type animals, despite similar food 
intake. This reduced consumption of oxygen (per unit mass) in the knockout animals 
was supported by a reduced expression of mitochondrial inner membrane uncoupling 
proteins, UCP2 and UCP3.  
 
Because double-muscled animals have an increased proportion of type IIB fibres 
(Girgenrath et al., 2005) one could expect the cellular metabolism of the double-
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muscled muscle to have an increased capacity for glycolytic metabolism. The role 
mitochondria play in glycolytic muscle fibres is not well characterised, nor is how 
they function differently from the mitochondria found in oxidative muscle fibres. But, 
as described in section 1.3.4, differences in the mitochondria are seen, and would 
have more impact in double-muscled animals due to the increase in glycolytic muscle 
fibres.  
 
The muscle would have a reduced capacity for oxidative phosphorylation due to a 
reduced COX activity (Gueguen et al., 2005B; Schmidt and Herpin, 1997; Jackman 
and Willis, 1996), and a reduction in the number of mitochondria (Schmidt and 
Herpin, 1997; Jackman and Willis, 1996). The mitochondria could be utilised to 
support basal and recovery metabolism, but could not be used during rapid 
contraction, as the muscles would be operating anaerobically due to the reduced 
myoglobin content (Donoghue et al., 2005; Kim et al., 2004), which helps sequester 
oxygen from the blood. The glycolytic fibres are adapted to this however by having 
increased levels of glycolytic enzymes (Hallauer and Hastings, 2002; Rivero et al., 
1998), which provides the quick ATP supply needed to produce the fast contractions 
seen in the type II fibres. But reliance on glycolysis to generate ATP occurs at the 
expense of lactate build-up due to pyruvate being converted to lactate to facilitate the 
re-oxidation of NADH.  
 
 
 
 
 16
Chapter 1 - Introduction and Literature Review 
1.4 Comparative proteomics 
Proteomes are the full compliment of proteins expressed by a given genome in a 
particular cell or sub-cellular organelle. Proteomes are dynamic in that they can be 
altered during development and by the changing conditions cells are subjected to. 
Whilst genetic methods of detecting changes in levels of gene expression goes some 
way to understanding what is happening in the various tissues, gene expression levels 
are not always translated into the functional units of the cell, the proteins. 
Comparative proteomics allows one to see differences in the level of proteins and has 
the added effect of not having to know what you are looking for. It involves the 
isolation of individual proteins, quantitating their expression and identifying the 
proteins which show differences. 
 
1.4.1 Two-dimensional electrophoresis comparative proteomics 
Two-dimensional electrophoresis (2-DE) is the primary separation tool used for 
proteomics investigations and will be used during this study. It involves separating a 
protein mixture first by the protein’s net charge by isoelectric focusing (IEF) and then 
by its molecular weight by sodium dodecyl sulphate - polyacrylamide gel 
electrophoresis (SDS-PAGE). It allows for the separation of hundreds of proteins on 
a single gel and can be quantitative (Encarnacion et al., 2005), allowing for 
differences in protein levels to be deduced. The gel format also allows various 
analyses to be carried out, protein identification by mass spectrometry (MS) or post 
translational modification (PTM) detection via western analysis. 
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Due to the IEF step, solubilising agents for 2-DE are limited to non-ionic detergents 
and denaturing agents. Generally urea and 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate (CHAPS) are used, however these agents are 
limited in their solubilising efficiency of hydrophobic proteins. Stronger non-ionic 
detergents and denaturants have been used with some success. Molloy et al. (1998) 
used urea, thio-urea, CHAPS and caprylyl sulfobetaine, and was able to detect seven 
hydrophobic outer membrane proteins in E. coli, two of which had not been detected 
in 2-DE gels before and another two had only been detected as open reading frames. 
For a hydrophobic protein to be resolved in a 2-DE gel, it not only has to be 
solubilised from the cell lysate, but also has to remain in solution throughout the 
focusing step. Many hydrophobic protein losses occur due to absorption to the gel 
matrix and precipitation as they approach their isoelectric point, resulting in the 
protein never being transferred to the second dimension (Adessi et al., 1997). Use of 
the non-ionic reducing agent tributyl phosphine (TBP) has been shown to alleviate 
this problem as TBP is not charged. This means that it does not migrate as the IEF 
progresses, so a constant amount is maintained throughout the gel to maintain the 
protein’s reduced state, aiding in its solubility (Herbert et al., 1998). 
 
Even though hydrophobic proteins are still difficult to resolve by 2-DE, many of the 
other problems it originally faced have been fixed in the last 25 years. When first 
introduced, carrier ampholyte gels were used for the IEF step. These yielded low 
resolution separations, had a limited loading capacity and showed low 
reproducibility. They were replaced with immobilised pH gradients (IPG) in which 
the chemicals producing the pH gradient were covalently anchored to the polymer 
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matrix. This allowed for the production of pH gradients which were stable over time, 
were reproducible, had a high loading capacity and could yield high resolution 
separations due to narrow pH gradients (less than 0.05pH/cm) (Gorg et al., 1988). 
IPGs which stretch to a pH of 12 have been developed so that proteins which are 
highly alkaline can now be resolved (Gorg et al., 2000). 
 
Due to the vast amount of different proteins and protein isoforms present in cells, 
strategies to increase resolution have had to be developed. The most common strategy 
to increase resolution is to use a narrower pH gradient, allowing for smaller 
increments in the pH. A series of overlapping pH gradients can then be used to assess 
the cell’s proteome (Gorg et al., 2004). Another strategy is to look at specific 
organelles in the cell individually, reducing the number of proteins to be assessed, 
and enabling them all to be resolved whilst maintaining a lower level of resolution 
(Ahmed and Rice, 2005). Molloy et al. (1998) utilised a differential extraction 
technique to separate proteins according to their solubility prior to separation by 2-
DE, again reducing the amount of protein to be resolved in each gel. 
 
1.4.2 Protein identification from 2-DE gels 
Proteins in this study were identified by peptide mass fingerprinting (PMF) and 
matrix assisted laser desorption ionisation – time of flight (MALDI-TOF) MS by 
performing an in-gel tryptic digest as outlined in Figure 1.2. This involves excising a 
piece of the gel containing the protein and destaining it, dehydrating the gel piece and 
drying it. Here the protein can be reduced and alkylated, if this was not performed 
prior  to running the  second dimension. It is then  incubated in trypsin, which cleaves  
 19
Chapter 1 - Introduction and Literature Review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Flow diagram of how proteins are identified from 2-DE gel plugs using 
in-gel tryptic digests and mass spectrometry. 
(A) Gel plugs are destained depending upon how they were stained. (B) After drying, 
reduction and alkylation of the protein can be performed. (C) The protein is cleaved 
into a series of peptides by trypsin. (D) Peptides are extracted from the gel plug into a 
solution. The peptides can then be analysed by (E) PMF using MALDI-TOF MS or 
(F) peptide sequencing by LC-MS/MS. (G) The resulting peptide masses or 
sequences can then be searched against a database to identify the protein. (adapted 
from Encarnacion et al., 2005) 
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the protein into a series of peptides which are extracted from the gel into a solution 
(Encarnacion et al., 2005) and laid on a MALDI-TOF target with a matrix, α-cyano-
4-hydroxy-cinnamic acid (HCCA), to facilitate sample ionisation.  
 
Because trypsin cleaves specifically on the carboxylic side of lysine and arginine 
residues, unless followed by a proline, the peptides resulting from digests are specific 
for the protein digested. The mass of these peptides are acquired by MS and matched 
against genetic databases, NCBI or SwissPROT, via a search engine, such as 
Mascot™. The databases contain protein sequences deduced from genetic sequences 
submitted to the database, which theoretical tryptic digests have been performed on 
and the masses of the resulting peptides calculated. Searching the NCBI database, 
significant matches are achieved by obtaining a protein score from the search, which 
is higher than that imposed by the database. The score required is altered by defining 
the organism which the sequence was derived from. If one is more specific with the 
organism the protein came from, the probability of the observed match being a 
random event is lowered, and the protein score is lowered. The protein score from the 
search is equal to –10 x log(P), where P is the probability that the observed match is a 
random event. The probability of this function can be altered by decreasing the error 
allowed for peptide matches, therefore increasing the certainty that the peptides do 
correspond to the peaks seen in the spectrum. 
  
The other method of identifying proteins by MS is to sequence the peptides, generally 
by liquid chromatography (LC) coupled with tandem MS (MS/MS). The peptides are 
separated out by reversed phase LC and then sequence information is acquired by 
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fragmentation of the peptide in the mass spectrometer. The resulting masses are used 
to deduce the peptide’s sequence, which is then searched against databases to identify 
the protein. Both of these methods require that the protein’s sequence already be 
present in the database to facilitate identification of the protein. However, if a novel 
protein was found in a sample, the sequence information acquired via tandem MS 
acts as a starting point for characterising the protein. By using different proteolytic 
enzymes, eventually a complete sequence can be built up as the proteinases will 
cleave at different locations and peptide sequences will overlap. 
 
Other methods of protein identification are avaliable. N-terminal sequencing by 
Edman degradation can be used much the same as peptide sequencing by LC-
MS/MS, matching an acquired sequence with those in protein databases. However 
this method has a sensitivity in the picamole range, where as MS can detect sample to 
a fentomole level. Western blotting with antibodies could allow for identification of 
proteins at a lower level than MS is capable of, but has the inherent disadvantage of 
having to know which protein you are looking for. 
 
Obtaining an adequate spectrum to identify a protein by MS generally requires a 
coomassie stained spot (10ng of protein). The use of more sensitive staining 
techniques, such as fluorescent stains (0.5ng of protein), means that less protein has 
to be loaded onto the gel to detect a protein, but identification via MS may not be 
possible due to not enough protein being present. To get around this, preparative gels, 
overloaded with protein, can be run at the same time as an analytical gel, loaded with 
less protein, is run. The nicely resolved analytical gel is used for quantitating the 
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protein expression levels, whilst the preparative gel is used for identifying the 
proteins which show modulation. 
 
1.4.3 Mitochondrial proteomics 
Mitochondrial proteomics using the standard 2-DE gel format described in section 
1.4.1 has been used to study mitochondria in various situations. From their 
involvement in neurodegenerative diseases (Zhang et al., 2005; Scheffler et al., 2001) 
and heart disease (Fountoulakis et al., 2005), to how they are affected by free radicals 
(Douette et al., 2006; Bailey et al., 2005). Mitochondria have also been shown to 
differentially express proteins in different tissues (Forner et al., 2006). The number of 
mitochondrial proteins detected by 2-DE vary depending on the staining and protein 
loading, one research group reporting detecting up to 1,200 individual proteins (Ruiz-
Romero et al., 2006), while others report seeing only 300 proteins (Zhang et al., 
2005; Scheffler et al., 2001). 
 
The limitation of using a 2-DE gel format for investigating the mitochondrial 
proteome is that many of the mitochondrial proteins are highly hydrophobic, and are 
unable to be resolved by 2-DE so it is restricted to looking at mostly matrix and inter-
membrane space proteins. To resolve the membrane bound fraction of the 
mitochondria, one must undertake extra measures such as sucrose density gradient 
fractionation (Hanson et al., 2001), affinity techniques to isolate specific complexes 
(Keeney et al., 2006; Schilling et al., 2005), or blue native electrophoresis (Brookes 
et al., 2002; Schagger and von Jagow 1991). 
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1.4.4 Muscle proteomics 
Only one comparative proteomics investigation has been undertaken comparing 
double-muscled and normal animals. Bouley et al. (2005) used 2-DE to separate 
skeletal muscle proteins from homozygote, heterozygote Belgian blue cattle and non-
double-muscled cattle. The resulting expression pattern showed modulation of 
different contractile proteins, as well as an increase in phosphoglucomutase and a 
decrease in fatty acid-binding protein in the double-muscled animal. This fits the 
increased proportion of glycolytic muscle fibres which they observed, as 
phosphoglucomutase is involved in glycolytic metabolism and fatty acid-binding is 
involved in oxidative respiration. 
 
Proteomics investigations have looked at mitochondrial proteins from skeletal 
muscle, but no studies, to my knowledge have looked specifically at the mitochondria 
in glycolytic fibres compared to those in the oxidative fibres. But several studies have 
looked at oxidative muscle tissue compared to glycolytic tissue. They generally found 
modulation in the levels of contractile proteins, varying between fast twitch isoforms 
and slow twitch forms, and modulation of some small heat shock proteins. But they 
also detected an up-regulation, in the oxidative fibres, of myoglobin levels as well as 
several metabolic proteins, including: Aconitase, ATP synthase, malate 
dehydrogenase, mitochondrial creatine kinase, NADH dehydrogenase and succinate 
dehydrogenase. The glycolytic fibres showed an increased level of glycerol-3-
phosphate dehydrogenase (Sayd et al., 2006; Donoghue et al., 2005; Okumura et al., 
2005). 
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Studies of this nature could help deduce how the mitochondria are functioning in the 
glycolytic fibres, as studies discussed in section 1.3.4 have shown that mitochondria 
isolated from glycolytic fibres show differences to those from oxidative fibres. But 
much more work needs to be done to deduce the role of the mitochondria in the 
glycolytic fibre. As yet, no work has been done on the mitochondria in the myostatin 
knockout model of double-muscling. Due to the increased proportion of glycolytic 
fibres in myostatin knockout animals, it also provides a model to look at changes 
associated with differences in muscle fibre type metabolism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25
Chapter 1 - Introduction and Literature Review 
1.5 Outline of this study 
Thus far, little work has been done on the metabolism of myostatin knockout animals, 
and no work has looked at how the mitochondria in the double-muscled animals are 
affected. This is despite the increased proportion of glycolytic fibres seen in the 
double-muscled animals, obviously impacting on the mitochondria at some level 
(Girgenrath et al., 2005). It is not known whether myostatin itself exerts any effect 
over mitochondria, but is quite possible as almost all of the mitochondrial proteins are 
translated from nuclear encoded genes (Paschen and Neupert, 2001). 
 
Because of the altered muscle metabolism seen in myostatin knockout mice, they 
serve as a unique model to further investigate differences seen in mitochondria from 
glycolytic muscle fibres, due to their increased proportion of type IIB fibres 
(Girgenrath et al., 2005). 
 
This study aims to: (i) verify the myostatin knockout status of the mice used during 
this study (ii) investigate whether the mitochondria from myostatin knockout mice 
show any differences in basal mitochondrial stress levels, and (iii) use a comparative 
proteomics approach to try and deduce if the mitochondria from knockout skeletal 
muscle are different from those found in wild type animals. 
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CHAPTER TWO 
Materials and Methods 
 
This chapter reviews the materials and methods which were utilised during this study. 
It includes all reagents, chemicals and solution compositions, as well as a detailed 
overview of the methods used. 
 
2.1 Materials 
Section 2.1 outlines the commercially available kits and reagents used, the 
composition of all stock solutions used, and a list of chemical suppliers. 
 
2.1.1 Commercial kits 
2.1.1.1 BCA protein estimation assay 
The bicinchoninic acid (BCA) protein assay kit was used to obtain an estimate of the 
total protein concentration present in samples. It was supplied by Pierce, Rockford, 
Illinois, USA. A list of its components and their contents are listed in Table 2.1: 
Table 2.1 BCA protein estimation assay 
Reagent Name Content 
BSA Standards Flame sealed ampules containing 1 mL of 2,000µg/mL 
BSA in 0.9% saline and 0.05% sodium azide 
BCA Reagent A Sodium carbonate, sodium bicarbonate, bicinchoninic 
acid, sodium tartrate in 0.1M sodium hydroxide 
BCA Reagent B 4% cupric sulfate 
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2.1.1.2 Silver stain plus kit 
The silver stain plus kit was used to silver stain 2-DE and SDS-PAGE gels. The kit 
was supplied by Bio-Rad, Hercules, California, USA. A list of its components and 
their contents are listed in Table 2.2: 
Table 2.2 Silver stain plus kit 
Reagent Name Content 
Fixative Enhancer Solution Glycerol 
Silver Complex Solution Silver nitrate, ammonium nitrate 
Reduction Moderator Solution Tungstosilicic acid hydrate 
Image Development Solution Formaldehyde 
Development Accelerator Reagent Sodium carbonate 
  
 
2.1.2 Antibodies 
Antibodies used and their sources are listed in Table 2.3: 
Table 2.3 Antibodies 
Antibody Product # Lot # Source 
Rabbit polyclonal to GDF8 / Myostatin Ab996-50 96001 Abcam 
Rabbit polyclonal to SOD2 SOD-110 02020602 Stressgen 
Rabbit polyclonal to hsp60 SPA-805 007408 Stressgen 
Rabbit polyclonal to actin (C-11)-R sc-1615-R K1904 Santa Cruz 
Goat anti-rabbit IgG (Whole Molecule) - 
Alkaline Phosphatase conjugate 
A3687 123K6037 Sigma 
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2.1.3 Enzymes 
Enzymes used and their sources are listed in Table 2.4: 
Table 2.4 Enzymes 
Enzyme Product # Lot # Source 
Trypsin Gold, Mass Spectrometry Grade V5280 203804 Promega 
    
 
2.1.4 Common solutions 
Common solutions were routinely made in the lab. Common solutions and their 
composition are listed in Table 2.5: 
Table 2.5 Common solutions 
Solution Composition 
PBS 8g NaCl (137mM) 
0.2g KCl (2.7mM) 
1.44g Na2HPO4 (4.0mM) 
0.24g KH2PO4 (1.7mM) 
Dissolve in 800mL of MilliQ water and adjust 
to pH 7, make up to 1L, and chill at 4°C 
  
1.5M Tris-HCl pH 8.8 90.83g Tris 
Dissolve in 400mL with MilliQ water, adjust to 
pH 8.8 with HCl, then make up to 500mL 
  
0.5M Tris-HCl pH 6.8 15.14g Tris 
Dissolve in 200mL with MilliQ water, adjust to 
pH 6.8 with HCl, then make up to 250mL 
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10% SDS 25g SDS 
Make up to 250mL with MilliQ water 
  
DTT Solution 250mg DTT in 0.5mL of MilliQ water 
Store at 4°C 
  
Stock Buffer (Westermeier’s) 6.06g Tris (0.5M) 
0.4g SDS (0.4%) 
Dissolve in 80mL of MilliQ water, adjust to pH 
6.8 with HCl, and make up to 100mL 
  
Sample Loading Buffer (Westermeier, 
1993) 
1g SDS (1%) 
0.003g EDTA (0.01mM) 
0.01g bromophenol blue (0.01%) 
1.0mL of DTT solution 
2.5mL stock buffer (Westermeier’s) 
10.0mL glycerol (10%) 
Make up to 100mL with MilliQ water 
  
5x Electrode Buffer 15g Tris (124mM) 
72g Glycine (959mM) 
50mL of 10% SDS (0.5%) 
Make up to 1L with MilliQ water 
  
Fixative 400mL of methanol (40%) 
100mL of acetic acid (10%) 
500mL of MilliQ water 
  
Coomassie Blue Stain 1g Brillant Blue R-250 (0.1%) 
Dissolve in 1L of fixative, and filter through #1 
filter paper 
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Towbin Transfer Buffer 7.207g glycine (192mM) 
1.514g Tris (25mM) 
1.87mL of 10% SDS (1.3mM) 
100mL of methanol (20%) 
Make up to 500mL with MilliQ water, and chill 
at 4°C 
  
10% Tween 20 25g Tween 20 
Make up to 250mL with MilliQ water 
  
10x Tris Buffered Saline (TBS) 12.10g Tris (0.1M) 
87.66g NaCl (1.5M) 
Dissolve in 800mL of MilliQ water, adjust to 
pH 7.7 with HCl, then adjust to 1L 
  
TBST 100mL of 10x TBS 
5mL of 10% Tween 20 (0.05%) 
Make up to 1L with MilliQ water 
  
Mitochondrial Isolation Buffer 42.78g sucrose (250mM) 
1.211g Tris (20mM) 
1.491g KCl (40mM) 
0.380g EGTA (2mM) 
0.5g BSA (1mg/mL) 
Make up to 500mL with MilliQ water, and chill 
at 4°C 
  
Mitochondrial Isolation Wash 5mL Percoll (5%) 
95mL of Mitochondrial Isolation Buffer 
Chill at 4°C 
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TENT Buffer 1.51g Tris (50mM) 
10.96g NaCl (150mM) 
0.37g EDTA (5mM) 
2.5mL of 50% (v/v) Triton X-100 (0.5%) 
Dissolve in 200mL of MilliQ water, adjust to 
pH 7.4 with HCl, and make up to 250mL 
Supplement with 0.4mM phenylmethylsulfonyl 
fluoride fresh daily 
  
8.5M Urea 51g urea 
Make up to 100mL with MilliQ water, treat 
with mixed bed ion exchange resin, vacuum 
filter, and store at -20°C in 10mL aliquots 
   
IPG Equilibration/Rehydration Solution 9.4mL of 8.5M Urea (8M) 
0.2g CHAPS (2%) 
100µL of 200mM TBP (2mM) 
50µL of 40% (w/v) 3-10 ampholytes (0.2%) 
Make up to 10mL with MilliQ water 
  
1% Bromophenol Blue 0.1g of bromophenol blue in 10mL of MilliQ 
water 
  
SDS-PAGE Equilibration Buffer 36g urea (6M) 
20mL of 10% SDS (2%) 
3.3mL of 1.5M Tris-HCl pH 8.8 (50mM) 
40mL of 50% (v/v) glycerol (20%) 
Make up to 100mL with MilliQ water, and store 
at -20°C in 12mL aliquots 
 
 
 
 32
Chapter 2 - Materials and Methods 
SDS-PAGE Equilibration Buffer I 240mg DTT (2%) 
12mL of SDS-PAGE Equilibration Buffer 
  
SDS-PAGE Equilibration Buffer II 300mg iodoacetamide (2.5%) 
12mL of SDS-PAGE Equilibration Buffer 
  
2-DE Agar Overlay 0.5g agarose LE (0.5%) 
0.003g bromophenol blue (0.003%) 
100mL of 1x electrode buffer 
Heat in microwave until agar dissolves, store in 
100mL schott bottle 
  
50mM Acetic Acid 14.3µL acetic acid 
Make up to 5mL with MilliQ water 
  
MALDI-TOF Wash Solution 5mL of 1% (v/v) TFA (0.1%) 
45mL of 11.11mM NH4H2PO4 (10mM) 
Store at 4°C 
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2.1.5 Common laboratory chemicals and reagents 
All common chemicals and reagents used and their sources are listed in table 2.6. 
Table 2.6 Chemicals and reagents 
Chemical or Reagent Source 
27% hydrogen peroxide Andrew Industrial Ltd 
  
Tris; D(+)-sucrose; ethylene glycol-bis-(beta-
aminoethyl ether)- N,N,N’,N’ tetracetic acid (EGTA) 
AppliChem 
  
Sodium chloride; sodium dodecyl sulphate; 
ethylenediaminetetra-acetic acid (EDTA); glycerol; 
Tween 20; Triton X-100 
BDH Ltd 
  
Dithiothreitol; beta-mercaptoethanol; ammonium 
persulphate; 40% 3-10 ampholytes; electrode wicks; 
mineral oil; 30% acrylamide, 2.67% bis- acrylamide; 
N,N,N',N'-tetramethylethylenediamine (TEMED); 
kaleidoscope pre-stained protein standard; silver stain 
plus kit; 3-10NL immobilised pH gradients 
Bio-Rad 
  
Peptide calibration standard; α-cyano-4-hydroxy-
cinnamic acid (HCCA) 
Bruker Daltonics 
  
Bovine serum albumin (BSA); 10kDa protein marker Invitrogen (Gibco BRL) 
  
Glycine Merck 
  
Bromophenol blue Park Scientific Ltd 
 
 
 
 34
Chapter 2 - Materials and Methods 
Bicinchoninic acid (BCA) protein assay kit; 1-
STEP™ NBT/BCIP 
Pierce 
  
Agarose LE Roche 
  
di-Sodium hydrogen phosphate dodecahydrate; 
methanol 
Scharlau 
  
Brilliant blue R-250; percoll; phenylmethylsulfonyl 
fluoride; urea; mixed bed ion exchange resin; 3-[(3-
cholamidopropyl) dimethylammonio]-1-
propanesulfonate (CHAPS); tributylphosphine (TBP); 
iodoacetamide; trifluoroacetic acid (TFA); sodium 
sulphite 
Sigma-Aldrich 
  
Potassium chloride; potassium dihydrogen 
orthophosphate; hydrochloric acid (HCl); glacial 
acetic acid; nitric acid; ammonium dihydrogen 
orthophosphate 
Univar 
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2.2 Methods 
 
2.2.1 Sample collection 
Skeletal muscle was dissected from the hind limbs of 14 week old wild type (WT) 
and myostatin knockout (KO) mice by Alex Henebry of the Growth and 
Development Group at AgResearch, Ruakura, Hamilton. 14 week old mice were used 
as they could show any changes in mitochondrial function after the ‘glycolytic 
switch’, mentioned in Chapter 1.2.1, which occurs within 39 days of birth (Girgenrath 
et al, 2005). 
 
The mice were asphyxiated with carbon dioxide and the Bicep Femorous, 
Gastrocnemius, Soleus, Quadriceps and Tibialis Anterior muscles removed and 
placed directly into ice cold mitochondrial isolation buffer (250mM Sucrose, 20mM 
Tris, 40mM KCl, 2mM EGTA, 1mg/mL bovine serum albumin (BSA)). One Bicep 
Femorous from each mouse used during the study was saved in a NUNC™ 
CryoTube™ (Invitrogen) and frozen at -70°C to verify the absence of myostatin 
protein in the KO mice. The other muscles were used for mitochondrial isolation on 
that day. 
 
As the animals used in this study were not subjected to any treatments, ethics 
approval was only required for the method of killing used (Protocol 650). This was 
approved by the University of Waikato’s Animal Ethics Committee on 21 October 
2005. 
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2.2.2 Myostatin knockout verification 
2.2.2.1 Protein extraction 
The Bicep Femorous muscle saved at -70°C was thawed in 1mL of PBS, stored at 
4°C, and minced with dissecting scissors. This was transferred to a 15mL falcon tube 
cut off at the 10mL mark and homogenized, using a disperser (IKA® T10 basic 
ULTRA-TURRAX®), for 15 secs at 20,500 rpm. A 5G stainless steel dispersion tool 
was utilised, this attachment has a working range of 0.5 to 5mL.  
 
The homogenate was left at 4°C for 1 hr for the cytosolic protein to solubilise and 
filtered through 75µm nylon net to remove connective tissue. This filtrate was 
aliquoted into 1.5mL microcentrifuge tubes and centrifuged at 16,000 rcf (Eppendorf 
5415R) for 4 mins at 4°C to pellet unsolubilised material. The supernatant was 
removed to a new tube and frozen at -20°C until required. 
 
2.2.2.2 Protein estimation 
BCA Protein Assay Kit (Pierce) was used to estimate the protein concentration of 
sample solutions by comparison against a BSA standard curve. This kit contains BCA 
Reagent A, BCA Reagent B, 10 x 1mL ampules of BSA at 2,000µg/mL. To see the 
content of these reagents, please refer to table 2.1. 
 
BSA standards in the range of 25 to 2,000µg/mL were made with PBS according to 
the manufacturer’s directions. Samples were diluted 1/5 with PBS to ensure they 
registered on the standard curve. 10µL of standards, including a PBS blank, and 
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samples were pipetted into a 96- well microtitre plate. Standards and samples were 
assayed in duplicate. 200µL of BCA working reagent (50 parts BCA Reagent A to 1 
part BCA Reagent B, which was mixed immediately before adding) was added to 
each well, the plate covered and incubated in a 37°C incubator (Contherm, 
Wellington, New Zealand) for 30 mins.  
 
After cooling to room temperature, the absorbance of each well was measured at 
570nm in a plate reader (Lab System Multiskan RC). DeltaSoft3™ software 
(BioMetallics, Princeton, NJ, USA) was used to control the plate reader and analyse 
the data. A linear standard curve was generated using the absorption values of the 
BSA standards. The concentration of the samples was then calculated using the 
formula of this line and the values for each sample. 
 
2.2.2.3 Sodium dodecyl sulphate – polyacrylamide gel electrophoresis 
The proteins were separated by discontinuous SDS-PAGE, using the method of 
Laemmli (1970). 0.75mm gels were cast/run using a Mini-Protean® 3 Cell gel 
apparatus (Bio-Rad) 
 
The 12% polyacrylamide separating gel consisted of 3.35mL MilliQ water, 2.5mL 
1.5M Tris-HCl pH 8.8, 100µL 10% (w/v) SDS, 4.0mL acrylamide-bis (30% 
acrylamide, 2.67% bis- acrylamide; Bio-Rad), 50µL of 10% (w/v) APS (Bio-Rad), 
prepared fresh daily, and 5µL of TEMED (Bio-Rad). A 4% stacking gel was laid on 
top of this and housed ten 5.08mm wells. This consisted of 3.05mL MilliQ water, 
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1.25mL 0.5M Tris-HCl pH 6.8, 50µL 10% (w/v) SDS, 650µL acrylamide-bis (30% 
acrylamide, 2.67% bis- acrylamide), 25µL of 10% (w/v) APS, prepared fresh daily, 
and 5µL of TEMED. Seen as there was no problem with inhibition of the acrylamide 
polymerization or air bubbles in the gel, neither of the gel monomer solutions were 
degassed. 
  
Protein samples were prepared by dilution with sample loading buffer (Westermeier, 
1993) according to the protein estimation, so that 20µg of protein could be loaded 
onto each lane within a volume of 10µL. 1 µL of Dithiothreitol (DTT) solution 
(250mg of DTT in 0.5mL of MilliQ water and stored at 4°C) was included in each 
sample to reduce disulphide bonds. This mixture was heated on a multi block heater 
(Lab-Line) at 95°C for 2 mins to break down the proteins’ secondary, tertiary and 
quaternary structure. 
 
The gels were assembled in the electrophoresis cell and 300mL of 1x electrode buffer 
(60mL of 5x electrode buffer and 240mL of MilliQ water) was added to the inner and 
lower buffer chambers. 10µL of each sample solution was loaded into a separate well 
using a Hamilton syringe. 4µL of Kaleidoscope pre-stained standard (Bio-Rad) was 
loaded onto the first lane of each gel to confirm transfer of the protein during the 
western blot and allow estimation of the molecular weight of the sample proteins. The 
gels were run at 200V (Power Pac 200, Bio-Rad) for 60 mins at room temperature. 
Duplicate gels were run at the same time, one for staining and the other for western 
blotting. 
 39
Chapter 2 - Materials and Methods 
The gel to be stained was removed from the gel cassette and placed in coomassie blue 
stain (0.1% (w/v) brilliant blue R-250 in 40% (v/v) methanol/10% (v/v) acetic acid) 
for 45 mins. It was then de-stained with successive lots of fixative (40% (v/v) 
methanol/10% (v/v) acetic acid) until the colour was removed from the background 
of the gel. The gel image was acquired on a MiniBIS Pro (DNR Bio-Imaging 
Systems, Jerusalem, Israel) controlled by GelCapture software (DNR Bio-Imaging 
Systems). 
 
2.2.2.4 Western blot 
Proteins separated on polyacrylamide gels were transferred to 0.45µm polyvinylidene 
fluoride (PVDF) membranes (Millipore) using a semi-dry transfer cell (Trans-Blot® 
SD, Bio-Rad). The gel was removed from the gel cassette and the stacking gel 
discarded. The separating gel was equilibrated in Towbin transfer buffer (192mM 
glycine, 25mM Tris, 1.3mM SDS, 20% (v/v) Methanol) for 5 mins. 
 
The PVDF membrane was activated by soaking in methanol for 10 mins and then 
equilibrated in Towbin transfer buffer, stored at 4°C, for 5 mins. Four pieces of extra 
thick blotting paper (Bio-Rad) were soaked in Towbin transfer buffer also. To 
perform the transfer, a sandwich was prepared as follows: two of the pieces of 
blotting paper were placed on the bottom platinum anode, the PVDF membrane was 
placed on top of these, followed by the equilibrated gel and the final two pieces of 
blotting paper. After each addition to the sandwich, air bubbles were removed by 
lightly rolling a 50mL falcon tube across the stack. The top stainless steel cathode 
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was placed on top of the sandwich and the proteins were transferred at 15V (Power 
Pac 200, Bio-Rad) for 60 mins at room temperature. The membrane was rinsed with 
MilliQ water, air dried at room temperature, and frozen at -20°C until required. 
 
2.2.2.5 Western analysis 
Non-specific binding sites on the membrane were blocked overnight at 4°C in a 5% 
(w/v) low-fat milk powder solution made up in TBST (150mM NaCl, 10mM Tris, 
0.05% (w/v) Tween 20). The following day it was washed three times in TBST for 5 
mins each. The membrane was incubated at room temperature for 90 mins in a 
1:2,000 dilution of primary antibody, rabbit polyclonal to GDF8/Myostatin (Abcam) 
made up in TBST. The membrane was again washed three times in TBST for 5 mins 
each. It was then incubated in a 1:100,000 dilution of the secondary antibody, anti-
rabbit IgG (whole molecule) conjugated to alkaline phosphatase grown in goat 
(Sigma) for 90 mins. The membrane was once again washed three times in TBST for 
5 mins each and rinsed in MilliQ water. The membrane was developed in a 1/10 
dilution of 1-STEP™ NBT/BCIP (Pierce), containing nitro blue tetrazolium made up 
in MilliQ water, for 60 secs and then immediately rinsed with MilliQ water to remove 
the substrate. 
 
An image of the western was acquired on a MiniBIS Pro (DNR Bio-Imaging 
Systems, Jerusalem, Israel) controlled by GelCapture software (DNR Bio-Imaging 
Systems). 
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2.2.3 Analysis of mitochondrial stress levels 
2.2.3.1 Mitochondrial isolation 
A mitochondria enriched fraction was isolated from the Gastrocnemius muscle using 
the method of Rustin (1993) with slight modifications. The muscle was weighed in 
5mL of fresh, ice cold mitochondrial isolation buffer. They were weighed in this 
manner to maintain the low temperature of the muscle and to avoid exposure to the 
air. The 5mL of solution was then supplemented with more mitochondrial isolation 
buffer so that there was 1mL per 100mg of tissue. All subsequent isolation 
procedures were performed at 4°C.  
 
The tissue was finely diced using dissecting scissors, and homogenized in a 50mL 
falcon tube using a disperser (IKA® T10 basic ULTRA-TURRAX®) operating at 
11,500 rpm for 15 secs. A 10G stainless steel dispersion tool was used to do this, 
which has a working range of 1 to 100mL. The homogenate was filtered through 
100µm nylon net to remove the connective tissue. 
 
1.5mL aliquots of the filtrate were placed in 1.5mL microcentrifuge tubes and 
centrifuged at 2,000 rcf for 8 mins (Eppendorf 5415R) to remove cell debris and 
nuclei. The supernatant was transferred to a new tube and spun at 10,000 rcf for 10 
mins to pellet the mitochondria. This supernatant was discarded and the pellet 
resuspended in 0.75mL of mitochondrial isolation wash buffer (mitochondrial 
isolation buffer supplemented with 5% (v/v) Percoll (Sigma)) by flicking the base of 
the tube with fingertips. The resuspended pellet was spun at 10,000 rcf for 10 mins 
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and the supernatant once again discarded. Excess solution was removed from the 
sides of the tube using filter paper strips and the mitochondria enriched pellet was 
frozen at -70°C until required. 
 
2.2.3.2 Protein solubilisation 
Each tube was resuspended in 40µL of TENT buffer (50mM Tris pH 7.4, 150mM 
NaCl, 5mM EDTA, 0.5% (v/v) Triton X-100, supplemented fresh daily with 0.4mM 
phenylmethylsulfonyl fluoride) using a Teflon micropestle (Eppendorf). This 
suspension was left at 4°C for 1 hr and then centrifuged at 4°C for 4 mins at 16,000 
rcf (Eppendorf 5415R). The resulting supernatants were removed to one 1.5mL 
microcentrifuge tube and stored at -20°C until required 
 
2.2.3.3 Protein separation and transfer 
Protein estimations were carried out on the samples as described earlier in section 
2.2.2.2. The samples were prepared for SDS-PAGE as described in section 2.2.2.3, 
however they were diluted so that 15µg of protein could be loaded on the gel in 15µL. 
After the gel had run at 200V (Power Pac 200, Bio-Rad) for 60 mins, one gel was 
stained with coomassie blue stain as described in section 2.2.2.3, whilst the other was 
transferred to a PVDF membrane as detailed in section 2.2.2.4. 
 
2.2.3.4 Western analysis 
The membrane was probed for hsp60 and SOD2 protein in the same manner as that 
outlined in section 2.2.2.5. However the antibodies and dilutions utilised were altered. 
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The primary antibody was at a 1:5,000 dilution in TBST. This was a polyclonal 
antibody grown in rabbit, specific for either hsp60 or SOD2 (Stresgen). The 
secondary antibody was still anti-rabbit IgG (whole molecule) conjugated to alkaline 
phosphatase grown in goat, however, this was used at a 1:50,000 dilution. The 
membrane was incubated in each of these as before, and developed in the same 
manner with a 1/10 dilution of 1-STEP™ NBT/BCIP substrate made in MilliQ water. 
 
An image of the western was acquired on a MiniBIS Pro (DNR Bio-Imaging 
Systems) and the band intensities measured using GelQuant (DNR Bio-Imaging 
Systems). The GelQuant software measures the pixel intensity of the bands on the 
western as a relative intensity compared to a reference band which is measuring 
background staining. So a value of 5 would mean that the band detected in the 
western is five times more intense than the background. 
 
2.2.3.5 Statistical analysis of western band intensities 
Statistical significance of any differences in the resulting western band intensity was 
performed using the student’s t-test. It employs the following formula to determine if 
differences seen in western band intensities between the WT and KO samples are 
statistically valid. 
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If the calculated t-value obtained from the sample is greater than the tabulated t-value 
the difference between the two sample means is deemed to be statistically valid. The 
tabulated t-value depends upon the degrees of freedom for the sample, df = n1+n2-2, 
and the required level of significance. 
 
2.2.4 Proteomic analysis of knockout mitochondrial protein levels 
Only the Gastrocnemius muscles were used in this section of the study. It was chosen 
for this because it is an easily isolated muscle of a reasonable size, as in 150mg of 
tissue per muscle instead of 45mg of tissue from a Soleus muscle. It also has a mixed 
fibre composition, so it can display the effect of the changes that occur in the 
mitochondria after the fibre type switch mentioned in Chapter 1.2.1, as opposed to 
using a muscle which is primarily composed of fast twitch fibres. 
 
2.2.4.1 Mitochondrial isolation 
A mitochondria enriched fraction was isolated from the gastrocnemius muscle as 
described in section 2.2.3.1, except that the finely diced muscle was homogenised in a 
15mL Potter-Elvehjem homogeniser (Wheaton Science, USA), by making 8 passes at 
a speed of 2,500 rpm. This was powered by a Baird and Tatlock motor with variable 
speed control. 
 
2.2.4.2 Protein solubilisation 
IPG rehydration/solubilisation solution was made fresh daily. It contained 8M urea, 
2mM TBP (Sigma), 2% (w/v) CHAPS (Sigma) and 0.2% (w/v) 3-10 ampholytes 
(Bio-Rad). The 8.5M urea stock used to make this was treated with mixed bed ion 
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exchange resin (Sigma) for 10 mins to remove charged species. It was then vacuum 
filtered through #1 filter paper (Advantec) to remove the ion exchange beads and 
frozen at -20°C until required. 
 
50µL of IPG rehydration/solubilisation solution was added directly to the 
mitochondrial pellet in each microcentrifuge tube. They were vortexed (Grant-Bio) 
twice for 5 secs each and left at 20°C for 1 hr so the protein could solubilise. The 
solution was centrifuged at 14,000 rcf in a miniSpin plus (Eppendorf) at room 
temperature for 4 mins to pellet unsolubilised material. The supernatant from each 
tube were transferred to a single tube which was kept at 20°C until required, this will 
subsequently be referred to as the IEF solution. TCA precipitation was not used in 
this study as the mitochondrial protein was in an already concentrated form after 
being pelleted during the mitochondrial isolation procedure described in section 
2.2.4.1. Proteolysis action was not considered a major problem, as many of the 
proteolytic agents would have been removed in the mitochondrial isolation step, and 
because the IPG rehydration/solubilisation solution used is denaturing would 
rendered them inactive. Another precaution which was not observed was DNA 
removal from the sample, as the major contaminating DNA in proteomics samples is 
the nuclear DNA, which once again has been removed during the isolation procedure.  
 
The pellets from each tube were resuspended in 25µL of TENT buffer with a Teflon 
micropestle (Eppendorf) and left at room temperature for 1 hr. The solutions were 
centrifuged at 14,000 rcf in a miniSpin plus (Eppendorf) at room temperature for 4 
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mins. The supernatant from each tube was transferred to a single tube and frozen at -
20°C until required. This solution will be referred to as the IEF pellet solution. 
 
2.2.4.3 IEF protein estimation 
The IEF solution was subjected to the protein estimation assay described in Section 
2.2.2.2 but with simple modifications. Because the IPG rehydration/solubilisation 
solution contains 8M urea, which interferes with the protein estimation assay, the 
standards and diluent used were altered to compensate for this. A 10,000µg/mL BSA 
solution was made up in IPG rehydration/solubilisation solution and frozen at -20°C 
in 100µL aliquots. This stock solution was diluted with 400µL of IPG 
rehydration/solubilisation solution to make a 2,000µg/mL solution and diluted further 
according to table 2.7 to make standards in the range of 125 to 2,000µg/mL. These 
standards replaced the standards in the previously described method. 
 
Table 2.7 Dilution scheme to make up standards to perform IEF protein estimation 
Final Concentration 
(µg/mL) 
Volume and Concentration 
of BSA Solution 
Volume of IPG Rehydration/ 
Solubilisation Solution 
2,000 100µL of 2,000µg/mL 0µL 
1,500 150µL of 2,000µg/mL 50µL 
1,000 100µL of 2,000µg/mL 100µL 
750 100µL of 1,500µg/mL 100µL 
500 100µL of 1,000µg/mL 100µL 
250 100µL of 500µg/mL 100µL 
125 100µL of 250µg/mL 100µL 
0 0µL 100µL 
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The rest of the protein estimation assay was the same as previously described, except 
that IPG rehydration/solubilisation solution was used as the blank and to dilute 
sample solutions.  
 
2.2.4.4 Isoelectric focusing 
IEF solutions were diluted with IPG rehydration/solubilisation solution so that the 
appropriate amount of protein could be loaded onto an IPG in 300 µL. WT and KO 
solutions were diluted to the same protein concentration so that the same amount of 
protein would be loaded onto each IPG. 0.2µL of 1% (w/v) Bromophenol blue 
solution was added to each millilitre of the diluted solution to track progress of the 
IEF. 300µL of sample was laid along the length of a 17cm IEF focusing tray (Bio-
Rad) and a 17cm 3-10NL IPG (Bio-Rad) laid on top of this. This was left for 1 hr and 
then overlaid with 1.4mL of mineral oil (Bio-Rad). The focusing tray lid was replaced 
and the IPG left to passively rehydrate for another 16 hrs at 20°C in a Protean® IEF 
Cell (Bio-Rad). 
 
Before running the IEF, the IPG was lifted at each end and an electrode wick (Bio-
Rad) wet with 8µL of MilliQ water placed between the electrode and the gel. The 
focusing tray was replaced in the IEF Cell and ran at 20°C with a current limit of 
50µA per gel. The focusing steps were as follows: the gels were held at 250V for 15 
mins, and then subjected to a rapid ramp over 3 hrs to 10,000V, where the voltage 
was maintained at 10,000V for 60,000V/hrs. After completion of the IEF the gels 
were held at 500V until removed from the IEF cell, to limit diffusion of the proteins. 
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After removing excess mineral oil on filter paper, the IPG was placed gel side up in a 
rehydration/equilibration tray (Bio-Rad), wrapped in cling film and frozen at -70°C 
until the second dimension was run. 
 
2.2.4.5 Second dimension – SDS polyacrylamide gel electrophoresis 
The IPG was prepared for the second dimension by equilibrating it in 6mL of SDS-
PAGE equilibration buffer I (6M Urea, 0.375 M Tris-HCl, pH 8.8, 2% (w/v) SDS, 
20% (v/v) glycerol, 2% (w/v) DTT) for 15 mins to reduce disulphide bonds. This was 
decanted off and replaced with 6mL of SDS-PAGE equilibration buffer II (6M urea, 
0.375 M Tris-HCl, pH 8.8, 2% (w/v) SDS, 20% (v/v) glycerol, 2.5% (w/v) 
iodoacetamide) for another 15 mins to acetylate the free thiol groups. The SDS-
PAGE equilibration buffer was stored in 12mL aliquots at -20°C until required and 
then supplemented with DTT or iodoacetamide on the day it would be used. 
 
After removing excess liquid, the IPG was laid on top of a 18.5cm by 20cm, 1.5mm 
thick, 12% SDS-PAGE gel consisting of 20.1mL MQ H2O, 15mL 1.5M Tris-HCl pH 
8.8, 600µL 10% SDS, 24mL acrylamide-bis (30% acrylamide, 2.67% bis- 
acrylamide), 300µL of 10% (w/v) APS prepared fresh daily, and 30µL of TEMED. A 
1% (w/v) agarose LE (Roche) gel plug, made in 1x electrode buffer, containing 10 
kDa protein markers (GibcoBRL®) was placed next to the acidic end of the IPG and 
both were covered in 2-D agar overlay, containing 0.003% (w/v) bromophenol blue 
to track progress of the electrophoresis. 
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The gel slab was loaded into a Protean II Xi gel apparatus with an IPG conversion kit 
(Bio-Rad). The gels were maintained at 15°C by circulating water, chilled by a 
refrigerated waterbath (RB-12A/TE-8D, Techne), through the cooling chamber and 
run at 35mA per gel (Power Supply 1000/500, Bio-Rad) for 5 hrs and 45 mins. 
 
2.2.4.6 Silver staining 
At completion of the electrophoresis, the gel was removed and stained using a silver 
stain plus kit (Bio-Rad). Silver stain plus is 60 times more sensitive than coomassie 
R-250 stains, but does not cross-link lysine residues like conventional silver stain, 
and therefore allows for downstream MS analysis. This kit contained fixative 
enhancer solution, silver complex solution, reduction moderator solution, image 
developer reagent, development accelerator reagent, and a 1L bottle to store the 
development accelerator solution. For composition of these reagents refer to table 2.2. 
The only preparation involved was to make up the development accelerator reagent to 
1L with MilliQ water, which could then be stored at 4°C for up to three months. 
 
All glassware and gel containers used for silver staining were washed in 2M nitric 
acid overnight and washed with MilliQ water. This is done to remove metallic silver 
residues which will act as nuclei for more silver deposition on the tray and cause 
inconsistent staining. Gels were fixed overnight in 400mL of 50% (v/v) methanol, 
10% (v/v) acetic acid and 10% (v/v) fixative enhancer solution. The next day they 
were rinsed three times over two hrs in 3 x 800mL of MilliQ water. The silver stain 
was prepared just prior to staining the gel. This involved mixing 52.5mL of MilliQ 
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water, 7.5mL of silver complex solution, 7.5mL of reduction moderator solution, 
7.5mL of image development solution, and 75mL of development accelerator 
solution at room temperature. The gel was agitated on a rocking platform (Bibby 
Sterlin Ltd), in this solution for 15 mins, then the staining solution was removed and 
the staining stopped with 400mL of 5% (v/v) acetic acid. After 15mins the acetic acid 
was removed and the gel left in MilliQ water. 
 
2.2.4.7 Quantitation of 2-DE spot intensities 
The gel image was captured on a luminescent image analyser (LAS-1000 plus, 
FujiFilm) controlled by Image Reader LAS-1000 Lite (FujiFilm). An exposure time 
of 1/60 secs was used. The resulting spot intensities were analysed using Image 
Gauge Version 4.0 (FujiFilm). The mouse was used to select an area that 
encompassed the spot of interest and also an area where no protein spots were present 
to be used as the background. Pixel intensities were expressed an arbitrary unit (AU) 
which were then divided by the size of the area selected in mm2 to take account of the 
different spot sizes present. The background (BG), also divided by its spot size, was 
then subtracted from the AU/mm2 to compensate for background staining. 
 
2.2.4.8 Statistical analysis of spot intensity differences between WT and KO gels 
Statistical significance of any differences in spot intensity between the WT and KO 
was determined as in section 2.2.3.5 using the student’s t-test. In this case, intensities 
from each of the three replicate gels from the WT and KO sample were used to 
determine if there was a statistically valid difference between the mean spot intensity. 
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2.2.4.9 In-gel tryptic digest 
Spots of interest were excised using 200µL pipette tips (Greiner Bio-one) cut off at 
the first mark, 12mm from the tip. They were deposited into 1.5mL microcentrifuge 
tubes and stored at -20°C until required. The gel plugs were destained in 300µL of 
1% (v/v) hydrogen peroxide (H2O2), added directly to the tube which the plugs were 
stored in, and shaken (MS1 mini shaker, IKA) overnight at 600 rpm. The destain 
solution was removed and the plugs washed in 200µL of 25mM NH4HCO3 for 15 
mins. After removing the wash solution, the plug was equilibrated in 100µL of 1:1 
25mM NH4HCO3/Acetonitrile (ACN) for 1 hr before dehydrating it in 50µL of ACN. 
The ACN was removed after 15 mins and the gel plugs left to air dry in a hood for 2 
hrs.  
 
Reduction and alkylation of the protein contained in the gel plug could have been 
performed prior to tryptic digestion. However, this was done when the IPG was 
prepared for SDS-PAGE and it was deemed unnecessary to redo this as peptides 
which were known to contain cysteine residues still identified with an alkylation 
modification.  
 
100µg of Trypsin Gold (Promega) was resuspended in 100µL of 50mM acetic acid to 
make a 1µg/µL solution which was stored in 2µL aliquots at -70°C. One of these was 
diluted in 398µL of 25mM NH4HCO3 to make a 0.005µg/µL trypsin solution. 15µL 
of this was added to each dehydrated gel plug and left at 4°C for 1 hr to rehydrate the 
gel. Excess trypsin solution was removed and the closed tubes were placed in a sealed 
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container with a wet paper towel to maintain humidity, which was incubated at 37°C 
for 6 hrs (Contherm Digital Series). The resulting peptides were extracted in 10µL of 
20% (v/v) ACN/0.1% (v/v) TFA overnight at 4°C. 
 
2.2.4.10 MALDI-TOF mass spectrometry of tryptic digest products 
As mentioned in Chapter 1.4.2, proteins were identified during this study, by PMF 
and MALDI-TOF MS. Because trypsin cleaves specifically on the carboxylic side of 
lysine and arginine residues, unless followed by a proline, the peptides resulting from 
digests are specific for the protein digested. MALDI-TOF MS can be used to quickly 
analyse the mass of each of the peptides present in the resulting digest mixture, as it 
gives only a singly charged, protonated ion within this mass range. 
 
Peptides samples were prepared for MALDI-TOF MS by applying 0.5µL of sample 
to a thinlayer of HCCA on a 600µm anchorchip (Bruker Daltonics). Once the sample 
had air dried in a hood, it was washed with 5µL of 0.1% (v/v) TFA in 10mM 
NH4H2PO4 for around 5 secs before removing and allowing to air dry again. 
 
The mass spectrometer used was an AutoFlex II™ (Bruker Daltonics) operated using 
FlexControl™ (Bruker Daltonics). The instrument was calibrated against a peptide 
calibration standard (Bruker Daltonics) which was loaded in the same manner as the 
samples, onto calibanchors, located at the centre of every four sample anchors. 
Sample spectra were acquired over a 500 to 4,000m/z range by summing 500 shots, 
with an acceleration voltage of 19kV and a reflector voltage of 20kV. Pulsed ion 
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extraction of 80ns was used to build up the concentration of ions in the ion source and 
ions below 500m/z were suppressed to avoid detector saturation from matrix ions. 
Spectra were automatically annotated by FlexAnalysis™ (Bruker Daltonics) to peak 
the mono-isotopic peaks within 800 and 4,000m/z, and Mascot™ database searches 
were performed via BioTools™ 3.0 (Bruker Daltonics), searching the NCBI database 
for sequences from either mammalia (mammals) or mus musculus (house mouse). 
 
2.2.4.11 SDS-PAGE of IEF pellet proteins 
The IEF pellet solution was subjected to the protein estimation assay described in 
section 2.2.2.2. The samples were diluted in sample loading buffer (Westermeier, 
1993) so that 1µg of protein could be loaded onto the polyacrylamide gel in a 15µL 
volume. The gel was run as previously described in section 2.2.2.3, however 10 kDa 
protein markers (GibcoBRL®) were run next to the samples. 
 
The gel was silver stained as described in section 2.2.4.6 with silver stain plus (Bio-
Rad). The only differences in the staining were the volumes used, 200mL of fixative 
and 50mL of stain (17.5mL of MilliQ water, 2.5mL of silver complex solution, 
2.5mL of reduction moderator solution, 2.5mL of image development solution, and 
25mL of development accelerator solution) was used. The gel was stained for 
15mins, stopped with 200mL of acetic acid and rinsed in MilliQ water. The gel image 
was captured on a LAS-1000 plus (FujiFilm) controlled by Image Reader LAS-1000 
Lite (FujiFilm), with an exposure time of 1/60 secs. 
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CHAPTER THREE 
Myostatin Knockout Verification 
 
3.1 Introduction 
Muscle tissues used during this study were acquired from the Growth and 
Development Group at AgResearch, Ruakura, Hamilton. The myostatin knockout 
mouse model was generated by genetic deletion of the third exon of the myostatin 
gene, which codes for the functional portion of the myostatin protein (McPherron et 
al., 1997). This results in a truncated myostatin protein which is unable to inhibit 
muscle growth leading to the myostatin knockout phenotype described in Chapter 
1.2.1. 
 
Even though this model has been well characterised and shown to not contain mature 
myostatin, at both mRNA and protein levels. Western blot analysis using anti-
myostatin antibodies raised against the mature portion of myostatin was carried out to 
verify that the knockout mice did not express the myostatin protein. 
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3.2 Materials and methods 
 
3.2.1 Sample preparation 
Bicep Femorous muscle were dissected from wild type (approximately 130mg) and 
myostatin knockout mice (approximately 190mg) as described in Chapter 2.2.1. This 
was stored in a NUNC™ CryoTube™ (Invitrogen) and frozen at -70°C until required. 
The muscle was diced in 1mL of PBS and homogenized as described in Chapter 
2.2.2.1. The homogenate was left at 4 °C for 1 hr for the cytoplasmic protein to 
solubilise, filtered through 75µm nylon net and centrifuged at 16,000 rcf to pellet the 
unsolubilised material.  
 
3.2.2 Western analysis 
An estimate of the total protein concentration was found using the BCA Protein 
Assay Kit (Pierce) as described in Chapter 2.2.2.2 to ensure equal protein loadings 
when protein was loaded onto SDS-PAGE gels. Cytoplasmic protein (20µg) was 
separated on 12% SDS-PAGE gels as outlined in Chapter 2.2.2.3. The protein was 
transferred to a 0.45µm PVDF membrane (Millipore) as in Chapter 2.2.2.4 by semi-
dry electroblotting. Western analysis was performed as described in Chapter 2.2.2.5. 
The membrane was blocked in TBST/5% milk powder at 4 °C overnight, washed in 
TBST and incubated in anti-myostatin antibody for 90 mins. The membrane was 
washed again and incubated in anti-rabbit IgG antibody coupled to alkaline 
phosphatase for 90 mins. The membrane was developed in a 1/10 dilution of 1-
STEP™ NBT/BCIP (Pierce). 
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3.3 Results 
3.3.1 Western analysis optimisation 
The antibody used in this study to detect myostatin, Rabbit polyclonal to GDF8 / 
Myostatin (Abcam), had not previously been used in our lab. This meant that the 
antibody dilutions used needed to be optimised, to obtain specific staining of the 
protein of interest whilst reducing background staining. The starting point for the 
primary antibody was taken at the manufacturers lowest advised concentration 
(1:5,000 dilution). A reasonably high concentration of secondary antibody was used 
(1:15,000 dilution) to ensure detection of the primary antibody. As can be seen in 
Figure 3.1 A, a faint band, marked with an arrow, is detected in the wild type sample 
at approximately 36kDa which is not detected in the knockout sample. But the 
antibodies are cross-reacting with the high abundance proteins in both the wild type 
and knockout samples. To try and reduce the background staining and increase the 
signal of the detected band, the primary antibody concentration was then increased to 
a dilution of 1:2,000 and the secondary antibody’s concentration decreased to 
1:50,000. Figure 3.1 B shows an increase in detection of the band and a reduction in 
the staining intensity of the other protein bands. The secondary antibody 
concentration was decreased further to 1:100,000, whilst maintaining the primary 
antibody’s concentration at 1:2,000. This is shown in Figure 3.1 C, with the 
background staining becoming fainter again. 
 
 
 
 
 
 
 
 57
Chapter 3 – Myostatin Knockout Verification 
 
 
 
 
 
 
 
 
Figure 3.1 Optimisation of anti-myostatin antibody staining in western blot analysis 
of wild type and knockout cytoplasmic skeletal muscle protein. (A) Western using a 
1:5,000 dilution of primary antibody and 1:15,000 dilution of secondary antibody. (B) 
Western using a 1:2,000 dilution of primary antibody and 1:50,000 dilution of 
secondary antibody. (C) Western using a 1:2,000 dilution of primary antibody and 
1:100,000 dilution of secondary antibody. 
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3.3.2 Myostatin knockout verification 
As mentioned in section 3.3.1, background staining was reduced but not eliminated in 
this experiment. However an intense band is seen in the wild type sample at 
approximately 36kDa, which is barely detectable in the knockout, marked with an 
arrow in Figure 3.2 A. The background staining which is observed in the western can 
be attributed to the most abundant proteins in each sample, by comparing the staining 
pattern in the western, Figure 3.2 A, with that of the coomassie stained 12% SDS-
PAGE gel, Figure 3.2 B. Figure 3.2 C is an intensity profile of each lane of the 
western and the gel laid side by side. It shows a similar profile between the western 
and the gel, for the wild type and the knockout lane, except for one location, marked 
with an arrow. This band detected on the wild type western is not present in the 
intensity profile for the corresponding gel lane, so cannot be attributed to a high 
abundance protein in the sample, nor is it detected in the knockout western. 
Interestingly, the molecular weight of this band does not correlate with the 52kDa full 
length myostatin protein, this will be discussed further in section 3.4. 
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Figure 3.2 Western blot and SDS-PAGE analysis of anti-myostatin staining pattern 
seen in wild type and knockout cytoplasmic skeletal muscle. (A) Western analysis 
showing an intense band at approximately 36kDa in the WT muscle which is barely 
present in the KO muscle. (B) Coomassie stained 12% SDS-PAGE gel replicating the 
separated proteins in the western. (C) Intensity profile of the WT and KO lanes from 
the western and the gel showing various matching peaks between the western and the 
gel for each lane, ‘W’ = western and ‘G’ = gel. 
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3.4 Discussion 
The intense band detected at 36kDa in the wild type sample and not in the knockout 
sample, could not be attributed to any of the highly abundant proteins in the samples. 
This molecular weight, however, does not correlate with that of full length myostatin 
(52kDa) or mature myostatin (12kDa). Interestingly, other researchers using 
antibodies raised against the mature portion of myostatin have observed a band 
between 36 and 40kDa which they attribute to the LAP, the cleavage product of full 
length myostatin shown in Figure 1.1 (McCroskery et al., 2003; Berry et al., 2002; 
Hill et al., 2002; Lee and McPherron, 2001; Thomas et al., 2000). 
 
If it is the LAP being detected, a further question to be asked is why it is not also 
being detected in the knockout samples. The genetic deletion of myostatin used in 
this mouse model only deletes the mature portion of myostatin (McPherron et al., 
1997), so the LAP should still be present. Whether the genetic deletion of the mature 
portion of myostatin in the knockout samples would cause the LAP to not be detected 
by anti-myostatin antibodies is unknown. The results of this study suggest that it does 
in some way reduce the binding of the anti-myostatin antibodies, as the LAP was 
barely detectable in the knockout mice. 
 
In the future, a myostatin antigen could be run at the same time as samples, this 
would allow one to check the specificity of the anti-myostatin antibodies. 
 61
Chapter 4 – Analysis of Mitochondrial Stress Levels 
CHAPTER FOUR 
Analysis of Mitochondrial Stress Levels 
 
4.1 Introduction 
As mentioned in Chapter 1.2.1, double-muscled cattle (due to non-functional 
myostatin being produced) have been shown to be more susceptible to environmental 
stressors including heat stress (Menissier, 1982). Heat stress is known to impair 
mitochondrial functions in skeletal muscle (Mujahid et al., 2006; Hsu et al., 1995), 
and is also known to induce mitochondrial stress proteins, such as hsp60 (Martinus et 
al., 1996). To determine if muscle tissue from myostatin knockout mice were being 
subjected to increased levels of mitochondrial stress, expression levels of heat shock 
protein 60 (hsp60) and superoxide dismutase 2 (SOD2) protein were assessed by 
western blot analysis. 
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4.2 Materials and methods 
 
4.2.1 Sample preparation 
A mitochondria enriched fraction was isolated from the Gastrocnemius muscle as 
described in Chapter 2.2.3.1. The muscle was homogenised, filtered, and the cell 
debris removed by centrifuging at 2,000 rcf. Mitochondria were pelleted at 10,000 
rcf, these were washed and then pelleted again. The protein from this mitochondria 
enriched fraction was solubilised in TENT buffer as in Chapter 2.2.3.2. 
 
4.2.2 Western analysis 
An estimate of the total protein concentration was determined using the BCA Protein 
Assay Kit (Pierce) as described in Chapter 2.2.2.2 to ensure equal protein loadings 
when samples were loaded onto SDS-PAGE gels. Mitochondrial protein (15µg) was 
separated on 12% SDS-PAGE gels as outlined in Chapter 2.2.2.3. The protein was 
transferred to a 0.45µm PVDF membrane (Millipore) as in Chapter 2.2.2.4 by semi-
dry electroblotting. Western analysis was performed as described in Chapter 2.2.3.4. 
The membrane was blocked in TBST/5% milk powder at 4 °C overnight, washed in 
TBST and incubated in a 1:5,000 dilution of primary antibody (anti-hsp60 or anti-
SOD2 (Stressgen)) for 90 mins. The membrane was washed again and incubated in a 
1:50,000 dilution of anti-rabbit IgG antibody coupled to alkaline phosphatase (Sigma) 
for 90 mins. The membrane was developed in a 1/10 dilution of 1-STEP™ 
NBT/BCIP (Pierce). 
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4.3 Results 
 
4.3.1 Mitochondrial stress levels  
Western analysis was performed on wild type and knockout mitochondria to 
determine the amount of hsp60 and SOD2 protein present in each. The coomassie 
blue stained 12% SDS-PAGE gel in Figure 4.1 A, was used to show consistent 
sample loadings during the separation of mitochondrial proteins by SDS-PAGE. The 
bands show little variation in protein levels between the wild type and knockout 
samples, except for the band just below 70,000Da. This is BSA from the 
mitochondrial isolation procedure, its level depends on how well excess solution was 
removed from the mitochondria enriched fraction. The western blots visually show no 
differences in band intensity for both hsp60, Figure 4.1 B, and SOD2, Figure 4.1 C. 
The graphs in Figures 4.2 A and B, which show the western band intensities measured 
on GelQuant (DNR Bio-Imaging Systems), further support this. They display very 
little difference in the intensity levels, of both stress proteins, between the wild type 
and knockout mitochondria. Student’s t-test was used to determine that there was no 
statistically significant difference between the two samples (p<0.05). 
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Figure 4.1 Expression of hsp60 and SOD2 in wild type and knockout skeletal muscle 
mitochondria. (A) Coomassie stained 12% SDS-PAGE gel replicate of western 
loadings, showing consistent sample loadings between WT and KO samples. (B) 
Western blot showing the protein levels of hsp60. (C) Western blot showing the 
protein levels of SOD2. 
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Figure 4.2 Quantitation of hsp60 and SOD2 protein levels in wild type and knockout 
skeletal muscle mitochondria. (A) Graph showing the level of hsp60 protein present 
in wild type and knockout mitochondria. The bars represent the average of four 
replicates, ± one standard deviation. No significant difference was seen by t-test. (B) 
Graph showing the level of SOD2 protein present in wild type and knockout 
mitochondria. The bars represent the average of three replicates, ± one standard 
deviation. No significant difference was seen by student’s t-test. 
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4.4 Discussion 
Similar levels of hsp60 and SOD2 were found in the wild type and myostatin 
knockout skeletal muscle mitochondria. Mitochondria which are not functioning 
properly produce more reactive oxygen species and express higher levels of stress 
proteins (reviewed in Reddy and Beal, 2005). These results indicate that the 
mitochondria from myostatin knockout skeletal muscle tissue are not being subjected 
to any increase in basal stress levels due to the knockout phenotype. 
 
To further investigate whether the knockout phenotype has any effect on the 
mitochondria’s ability to respond to stressors, mice could have been placed in a stress 
inducing environment (such as restraint, or raised temperature) prior to sample 
collection, or cultured myoblast cells from wild type and knockout skeletal muscle 
could have been subjected to in-vitro stressors. 
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CHAPTER FIVE 
Proteomic Analysis of Knockout Mitochondrial Protein Levels 
 
5.1 Introduction 
A comparative proteomics approach was used to detect if there were any differences 
in expression of proteins from myostatin knockout skeletal muscle mitochondria 
compared to those from wild type mice. This was performed on a 2-DE gel format, 
where proteins are separated first by their net charge and then by their molecular 
weight, allowing for the separation of hundreds of proteins (Encarnacion et al., 2005). 
 
Comparative proteomics involves separating out individual proteins, quantitating 
their expression, looking for differences and then identifying the proteins which are 
modulated. In this study, proteins were separated by 2-DE. After optimisation of the 
level of protein loaded onto the 2-DE gel and reproducible profiles were obtained 
between replicate gels, expression levels were quantitated by silver staining. The 
resulting spot intensities were analysed for differences and proteins identified by in-
gel tryptic digestion and MALDI-TOF MS. 
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5.2 Materials and methods 
 
5.2.1 Sample preparation 
A mitochondria enriched fraction was isolated from the Gastrocnemius muscle as 
described in Chapter 2.2.4.1. The muscle was homogenised, filtered, and the cell 
debris removed by centrifuging at 2,000 rcf. Mitochondria were pelleted at 10,000 
rcf, these were washed and then pelleted again. The protein from this mitochondria 
enriched fraction was solubilised in IPG rehydration/solubilisation solution as in 
Chapter 2.2.4.2. An estimate of the total protein concentration was determined using 
the BCA Protein Assay Kit (Pierce) as described in Chapter 2.2.4.3 to ensure equal 
protein loadings onto IPGs. The IEF pellet protein was solubilised in TENT buffer as 
in Chapter 2.2.4.2 and protein estimation carried out as detailed in Chapter 2.2.2.2. 
 
5.2.2 Two-dimensional gel electrophoresis 
17cm 3-10NL IPGs (Bio-Rad) rehydrated in the IEF solution doped with 0.0002% 
bromophenol blue, as detailed in Chapter 2.2.4.4, for 17 hrs at 20°C. The rehydrated 
IPGs were focused at 10,000V for 60,000V/hrs. The focused IPG was prepared for 
the second dimension by equilibrating in SDS-PAGE equilibration buffer with DTT 
and then with IAA, as outlined in Chapter 2.2.4.5. The IPG was laid on a SDS-PAGE 
gel and electrophoresed at 15°C for 5 hrs and 45 mins. The gel was stained with 
silver stain plus (Bio-Rad), MS compatible silver stain, as in Chapter 2.2.4.6, the 
subsequent spot intensities measured using Image Gauge Version 4.0 (FujiFilm), as 
described in Chapter 2.2.4.7. 
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5.2.3 Protein identification 
Spots of interest were excised and digested with trypsin, as detailed in Chapter 
2.2.4.9, for PMF identification. Gel plugs were destained in 1% H2O2, washed with 
25mM NH4HCO3, equilibrated in 1:1 25mM NH4HCO3/ACN, and dehydrated in 
ACN. The plug was air dried and rehydrated in a 0.005µg/µL trypsin solution at 4°C 
for 1 hr. Excess trypsin was removed and the plug incubated at 37°C for 6 hrs. The 
resulting peptides were extracted overnight at 4°C in 20% ACN/0.1% TFA. Peptide 
masses were determined using MALDI-TOF MS, as described in Chapter 2.2.4.10. 
Identifications were made by Mascot™ database searches which were performed via 
BioTools™ 3.0 (Bruker Daltonics). 
 
5.2.4 SDS-PAGE of IEF pellet proteins 
Protein estimation was performed using the BCA Protein Assay Kit (Pierce) as 
described in Chapter 2.2.2.2 to ensure equal amounts of protein were loaded onto 
SDS-PAGE gels. IEF pellet protein (1µg) was separated on a 12% SDS-PAGE gel as 
outlined in Chapter 2.2.4.11, which was silver stained and imaged. 
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5.3 Results 
 
5.3.1 Two-dimensional electrophoresis gel protein loadings  
As a starting point, it was unknown how much protein to load onto the 2-DE gels, so 
the first study to be undertaken was to load known amounts of protein, to determine 
how much sample protein to load. 100, 200 and 300µg of protein was loaded onto 17 
cm 3-10NL IPGs, and the 2-DE gels were run and visualised as usual. As more 
protein is loaded on the gel, more proteins can be seen, but some resolution is lost as 
closely migrating proteins begin to obscure each other. Figure 5.1 A shows a loading 
of 100µg, at this loading approximately 80 spots are visible. Figure 5.1 B is a loading 
of 200µg, with this amount of protein loaded, approximately 120 spots are present. 
Figure 5.1 C is loaded with 300µg of protein, this gel shows 180 spots, but it is 
starting to look overloaded with vertical and horizontal streaks appearing.  
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Figure 5.1 Visualisation of mitochondrial proteins separated by 2-DE as a function 
IPG protein loadings. 17cm 3-10NL IPG loaded with different of mitochondrial 
protein, second dimension run on a 12% SDS-PAGE gel, stained with silver stain 
plus MS compatible silver stain (A) 100µg of protein loaded. (B) 200µg of protein 
loaded. (C) 300µg of protein loaded. (See Appendices A to C for full page versions) 
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The horizontal streaking is due to the IEF not being run long enough for the amount 
of protein present to focus. The IEF method could have been adjusted by increasing 
the amount of V/hrs the IPG had to be maintained at 10,000V, so that the protein 
could focus properly. The vertical streaking is from protein not equilibrating properly 
before SDS-PAGE and could have been alleviated by equilibrating the IPGs for 
longer prior to running the second dimension, possibly agitating them to aid diffusion 
of the solution into the IPG. Because an outside source was relied upon for the 
samples used during this study, the amount of sample was limited, and a lower 
protein loading was opted for. A loading amount between 200 and 300µg (220µg) 
was chosen to use with the experimental samples. This amount allows for 
approximately 160 spots to be visualised, whilst still maintaining resolution and 
keeping within sample availability. 
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5.3.2 Reproducibility of two-dimensional electrophoresis gels 
One of the major issues with 2-DE has always been the low level of reproducibility. 
Reproducibility of the isoelectric focusing step has been improved since the 
introduction of commercially available IPGs (Gorg et al., 1988). However, the 
greatest reproducibility issue faced during this study was maintaining a consistent 
protein loading from gel to gel. There are a number of issues confronted when 
rehydrating an IPG with the sample solution. The volume of sample must be the same 
if the amount of protein loaded is to be consistent and all of this solution must be 
absorbed by the gel. If the sample solution splashes onto the IPG’s plastic backing, or 
if it is beaded by the mineral oil used to overlay the IPG, it will not enter the gel. 
Lastly, the higher molecular weight proteins cannot enter the IPG until the gel has 
rehydrated enough so that the protein can fit through the gel’s pores. But the IPG 
cannot be left to rehydrate too long or it will dry out and chemicals in the IEF 
solution will begin to break down.  
 
Figure 5.2 shows a set of four 2-DE gels which were run using the same IEF sample 
solution. Figures 5.2 A and C show low protein loadings for gels which were 
supposedly loaded with 220µg of protein. By looking back at Figure 5.1, these two 
gels look to have an intermediate amount between 100µg (Figure 5.1 A) and 200µg 
(Figure 5.1 B). Figure 5.2 B contrasts the previous two gels mentioned, having a very 
large protein loading, possibly even more than that seen with 300µg (Figure 5.1 C) of 
protein loaded. Figure 5.2 D has a loading closer to what would be expected for 
220µg of protein.  
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Figure 5.2 Reproducibility of 2-DE gel protein loadings. 17cm 3-10NL IPG loaded 
with 220µg of mitochondrial protein, second dimension run on a 12% SDS-PAGE 
gel, stained with silver stain plus MS compatible silver stain (A) Replicate number 
one. (B) Replicate number two. (C) Replicate number three. (D) Replicate number 
four. (See Appendices D to G for full page versions) 
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5.3.3 SDS-PAGE analysis of the insoluble fraction of the IEF solution  
As mentioned in Chapter 1.4.1, 2-DE is generally not capable of resolving 
hydrophobic proteins, unless measures are taken to increase the solubilising power of 
the solution used. In an attempt to gauge the level of protein which was being lost in 
the solubilisation step, the pellet left after the mitochondrial protein was solubilised in 
IPG rehydration/solubilisation solution was re-solubilised in TENT buffer, see 
Chapter 2.2.4.2 for details. The amount of protein retrieved from these pellets 
accounted for only 3% of the total amount of protein retrieved, showing that either 
the TENT buffer was ineffective in solubilising the remaining protein or most of the 
protein had been solubilised in the IEF solution. These pellet proteins were run on a 
12% SDS-PAGE gel and as is seen in Figure 5.3 relatively few proteins were 
detected by silver stain. This, and the low amount of protein detected by BCA protein 
estimation (detailed in Chapter 2.2.2.2), suggests that many of the hydrophobic 
proteins may have been solubilised and were not resolved in the 2-DE gels as they 
were lost on the IPG matrix or precipitated out of solution during focusing, as 
described by Adessi et al. (1997).  
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Figure 5.3 Separation of proteins remaining after solubilisation in IPG 
rehydration/equilibration solution. WT and KO IEF pellet protein (1µg) separated on 
a 12% SDS-PAGE gel and stained with silver stain plus MS compatible silver stain. 
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5.3.4 Mitochondrial 2-DE protein map of WT and KO gastrocnemius muscle  
A reproducible gel set was achieved by taking immense care during the IPG loading 
stage. This consisted of three wild type gels and three knockout gels, each showing 
mitochondrial proteins from the gastrocnemius muscle separated by their isoelectric 
point and then by their molecular weight. Figure 5.4 A is a representative gel from the 
wild type sample, and Figure 5.4 B is a representative from the knockout sample. The 
full set of 2-DE gels can be found in Appendices H to M.  
 
Each of these replicates showed a consistent loading pattern and approximately 160 
individual protein spots were detected by silver staining. There is a concentration of 
proteins in the alkaline region of the gel, and in the higher molecular weight acidic 
region. Few proteins were resolved in the neutral pH region. Proteins of a low 
molecular weight were not resolved well, showing large amounts diffusion and no 
proteins over a molecular weight of 90kDa were ever seen. 
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Figure 5.4 2-DE gels of wild type and knockout mitochondrial protein. 17cm 3-10NL 
IPG loaded with 220µg of mitochondrial protein, second dimension run on a 12% 
SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. (A) Wild 
type sample. (B) Knockout sample. (See Appendix H to M for full page versions of 
entire gel set) 
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5.3.5 Modulation of mitochondrial proteins seen in knockout skeletal muscle 
70 of the 160 spots detected in the 2-DE gels had their spot intensity analysed using 
Image Gauge (FujiFilm). These were chosen on the basis of spots which had already 
had proteins identified and others which showed visible differences. The assigned 
spot numbers are displayed on a 2-DE map in Figure 5.5. 
 
As shown in Table 5.1, the majority of the spots quantitated showed no difference in 
expression between the wild type and knockout mitochondria. However some 
proteins did show significant changes in their levels of expression. Spot numbers 49 
and 68 were up-regulated in the knockout sample and numbers 63 and 67 was down-
regulated, but were only significant at p<0.1. Spot number 59 was expressed 1.2 
times less in the knockout mitochondria (p<0.05) and number 46 was expressed 2.4 
times higher (p<0.005). However, all these modulated proteins were expressed at 
levels too low to be identified during this study. 
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Figure 5.5 2-DE gel showing assigned spot numbers. These spot numbers were 
assigned to spots which already had proteins identified and others which showed 
visible differences in intensity. The pixel intensity of only these spots was measured. 
Arrows to the right hand side of a spot number indicates an up-regulation (↑) or 
down-regulation (↓) in the KO sample, which was at a level of significance of at least 
p<0.1. 
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Table 5.1 Modulation of knockout proteins shown by changes in 2-DE spot 
intensities. Table listing the change in spot intensity, significance level of that change 
and protein which that spot corresponds to (if that protein has been identified). 
 
Spot Change Sig. Protein 
1 ↑ 1.4  Glucose Regulated Protein 75
2 ↓ 1.5  Aconitase 2 
3 ↓ 1.2  Aconitase 2 
4 ↓ 1.1  Aconitase 2 
5 ↑ 1.2  BSA 
6 N/C  Inner Membrane Protein 
7 ↓ 1.1  Heat Shock Protein 60 
8 N/C  Heat Shock Protein 60 
9 ↓ 1.1  Heat Shock Protein 60 
10 N/C  Dihydrolipoamide Dehydrogenase 
11 ↓ 1.2  Dihydrolipoamide Dehydrogenase 
12 N/C  Dihydrolipoamide Dehydrogenase 
13 ↓ 1.2  Aldehyde Dehydrogenase 6a1 
14 ↓ 1.1  Not Identified by PMF 
15 N/C  ATP Synthase, H+ transporting, F1 complex, beta subunit 
16 ↓ 1.2  Not Identified by PMF 
17 ↓ 1.1  Not Identified by PMF 
18 N/C  ATP Synthase, H+ transporting, F1 complex, alpha subunit 
19 ↑ 1.1  Not Identified by PMF 
20 ↑ 1.2  Not Identified by PMF 
21 ↑ 1.1  Enolase 3 
22 N/C  Fumarate Hydratase 1 
23 ↑ 1.1  Fumarate Hydratase 1 
24 ↑ 1.1  Fumarate Hydratase 1 
25 ↓ 1.2  Succinate-CoA ligase, beta subunit 
26 ↓ 1.1  IsoValeryl CoA Dehydrogenase 
27 N/C  Creatine Kinase 
28 N/C  Creatine Kinase 
29 N/C  Isocitrate Dehydrogenase 3, beta subunit 
30 N/C  Aldolase A 
31 ↓ 1.1  Not Identified by PMF 
32 ↓ 1.2  Pyruvate Dehydrogenase, beta subunit 
33 N/C  Pyruvate Dehydrogenase, beta subunit 
34 N/C  Malate Dehydrogenase 2 
35 N/C  Malate Dehydrogenase 2 
36 N/C  Malate Dehydrogenase 2 
37 N/C  Electron Transferring Flavoprotein, beta subunit 
38 N/C  Voltage Dependent Anion Channel 1 
39 N/C  Voltage Dependent Anion Channel 1 
40 N/C  Voltage Dependent Anion Channel 1 
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41 ↓ 1.2  Prohibitin 
42 N/C  Prohibitin 
43 ↓ 1.1  Not Identified by PMF 
44 ↑ 1.2  Not Identified by PMF 
45 N/C  Not Identified by PMF 
46 ↑ 2.4 p<0.005 Not Identified by PMF 
47 N/C  Electron Transferring Flavoprotein, alpha subunit 
48 N/C  Hydroxyacyl-Coenzyme A Dehydrogenase 2 
49 ↑ 1.3 p<0.1 Not Identified by PMF 
50 N/C  ES1 
51 N/C  Not Identified by PMF 
52 N/C  Super Oxide Dismutase 2 
53 N/C  Super Oxide Dismutase 2 
54 N/C  Apolipoprotein A-1 
55 N/C  NADH Dehydrogenase (Ubiquinone) Flavoprotein 2 
56 ↓ 1.1  ATP Synthase, H+ transporting, F0 complex, subunit d 
57 ↑ 1.1  Adenylate Kinase 1 
58 N/C  ATP Synthase, H+ transporting, F0 complex, subunit d 
59 ↓ 1.2 p<0.05 Not Identified by PMF 
60 ↑ 1.1  Peroxiredoxin 3 
61 ↓ 1.4  Not Identified by PMF 
62 ↑ 1.1  Not Identified by PMF 
63 ↓ 2.1 p<0.1 Not Identified by PMF 
64 ↑ 1.1  Not Identified by PMF 
65 ↓ 1.1  Not Identified by PMF 
66 N/C  Not Identified by PMF 
67 ↓ 1.3 p<0.1 Not Identified by PMF 
68 ↑ 1.4 p<0.1 Not Identified by PMF 
69 ↑ 1.3  Nucleoside-Diphosphate Kinase 2 
70 ↓ 1.3  Not Identified by PMF 
Spot numbers correspond to those shown in Figure 5.5. Change in protein expression is 
expressed as a fold increase or decrease in the knockout spot intensity compared to wild 
type spot intensity. ↑ signifies an up-regulation of protein in the knockout mitochondria 
and ↓ signifies a down-regulation, N/C signifies no change in protein expression. Levels of 
significance were determined by student’s t-test. A full list of information on identified 
proteins is available in Appendix N. 
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An attempt was made to identify the proteins in spots 46 and 59, by combining gel 
plugs from each of the 2-DE gels and performing a tryptic digest as per usual. Gel 
plugs for spot 46 came from the knockout gels, and plugs for spot 59 came from the 
wild type gels, as this was the sample each was expressed at higher amounts in. But 
this still yielded only low spectra, Figure 5.6 B shows the spectrum acquired from 
spot 46. Compared to the spectrum in Figure 5.6 A, which was used to identify spot 4 
as Aconitase 2, sample 46’s peak intensities are low and the spectrum has a rising 
baseline in the low mass region as the laser power had to be increased to ionise the 
sample. The peak at m/z = 842.5 is a cleavage product of trypsin acting upon itself. 
 
Many of the proteins which were identified did not show statistically significant 
changes in expression levels between the wild type and knockout mitochondria, but 
are important metabolic enzymes or critical to the proper functioning of the 
mitochondria. These proteins will be discussed further in section 5.4. 
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Figure 5.6 MALDI-TOF spectra of tryptic digests. (A) Spectrum of the tryptic digest 
of spot number 4, which was identified as aconitase 2. (B) Spectrum of the tryptic 
digest of spot number 46, which could not be identified by PMF. 
 85
Chapter 5 – Proteomic Analysis of Knockout Mitochondrial Protein Levels 
 
5.4 Discussion 
 
5.4.1 Loading of two-dimensional electrophoresis gels 
This study identified two parameters that needed to be addressed prior to achieving 
reproducible 2-DE gels. 
 
a) The amount of protein loaded had to be optimised, if too little was loaded not 
many spots were detected, if too much was loaded vertical and horizontal 
streaking appeared.  
 
b) And the IPGs had to be rehydrated very carefully, to avoid protein being lost 
on its backing or in the mineral oil overlay. This was found to be the most 
important parameter to obtain a consistent loading between gels, as gels laid 
from the same solution, with the same volume which were left to rehydrate for 
the same amount of time showed vast differences in their protein loading. 
 
Attempts to normalise the spot intensities obtained from each gel against a protein 
maintained at a consistent level in mitochondria, such as actin, were unsuccessful as 
the protein was present in quantities below the detection limits of this study. 
 
5.4.2 Protein detection and identification from 2-DE gels 
Estimates of the total number of proteins present in the mitochondria vary between 
1,000 to 2,000 proteins, these numbers are gauged from genomic analysis with only 
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685 of these being identified at a protein level (Gibson, 2005). In the final 2-DE gel 
set, around 160 spots were visualised using silver stain plus (Bio-Rad). This 
corresponds to around one tenth of the proteins present in the mitochondrial 
proteome. Granting that many of the proteins present in the mitochondria are 
hydrophobic proteins and are difficult to resolve by 2-DE, there are still many more 
hydrophilic proteins present in the mitochondria which cannot be seen in this gel set.  
 
Two strategies could have been undertaken to detect more of this portion of the 
mitochondrial proteome. The amount of protein loaded onto the gel could have been 
increased, but as explained in section 5.3.1, this leads to a reduction in resolution and 
sample availability did not allow for this. A more sensitive detection method could 
have been used, fluorescent staining would have given a two fold increase in 
detection. This was not undertaken because increasing the staining sensitivity would 
still not allow for the newly detected proteins to be identified as the level of protein 
present would still be below that required to obtain a spectrum capable of positive 
identification by PMF. 
 
Of the 160 protein spots detected in the 2-DE gels, only 29 of these were identified as 
a known protein. The general consensus for identification of a 2-DE protein spot is a 
coomassie blue stained spot (10ng of protein), seen as silver stain (1ng of protein) 
was used during this study, many of the spots seen were not able to be identified. To 
identify more of the proteins seen in the 2-DE gels, one would have to load more 
protein onto the gel. Preparative gels could have been run as described in Chapter 
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1.4.2, but was not applied during this study due to sample restrictions and economic 
constraints. 
 
5.4.3 Relevant protein identifications from 2-DE gels 
Once a reproducible 2-DE gel set was obtained, modulation and identification of the 
proteins detected in the knockout skeletal muscle mitochondria was undertaken. Four 
of these proteins showed changes at the p<0.1 level, and two proteins showed 
changes at a level of significance greater than p<0.05. Unfortunitely, none of these 
proteins were able to be identified during this study by PMF. 
 
Hsp60 and SOD2 proteins were identified during the 2-DE analysis. Similar levels of 
expression were observed between wild type and knockout mitochondria in this 
study, which is in agreement with the western blot analysis detailed in Chapter 4. 
 
Nearly all of the proteins identified in the 2-DE gels were high abundance 
mitochondrial proteins. None of these showed any significant change in expression 
but are important mitochondrial proteins.  
 
Aconitase 2 (Spots 2, 3 and 4), fumarate hydratase 1 (Spots 23, 24 and 27), succinate-
CoA ligase (Spot 25), isocitrate dehydrogenase 3 (Spot 29), malate dehydrogenase 2 
(Spots 34, 35 and 36) and nucleoside-diphosphate kinase 2 (Spot 69) are all enzymes 
present in the TCA cycle involved in the oxidation of acetyl-CoA and the subsequent 
generation of NADH used to produce ATP via oxidative phosphorylation (Garrett 
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and Grisham, 1999). Aconitase has been implicated in aging, as its activity declines 
more dramatically than the other TCA enzymes (Yarian et al., 2006), this is theorised 
to be because of oxidative modifications to the protein (Hunzinger et al., 2006). The 
NADP+ dependent isoform of isocitrate dehydrogenase generates NADPH which is 
used to regenerate reduced glutathione an essential part the NADPH-dependent 
thioredoxin system for detoxifying ROS produced by aerobic metabolism (Kim et al., 
2005; Kil et al., 2004). Impaired fumarate hydratase has been linked with cancer, as a 
build up of fumarate in the TCA cycle, due to inactive fumarate hydratase, inhibits 
prolyl hydroxylase enzymes in the cell, producing an apoptosis-resistant phenotype 
(King et al., 2006).  
 
Pyruvate dehydrogenase beta (Spots 32 and 33) and dihydrolipoamide dehydrogenase 
(Spots 10, 11 and 12) are two of the components which make up the pyruvate 
dehydrogenase complex, which is the link between glycolysis and the TCA cycle. 
Dihydrolipoamide is a regulatory subunit of the complex, being allosterically 
inhibited by either of its products, acetyl-CoA and NADH (Garrett and Grisham, 
1999). Defects in pyruvate dehydrogenase results in impaired aerobic metabolism and 
has been shown to cause congenital lactic acidosis (Saijo et al., 1997) as well as 
being linked with several neurodegenerative diseases (Klivenyi et al., 2004). Other 
enzymes important in metabolic pathways outside of the TCA cycle are isovaleryl-
CoA dehydrogenase (Spot 26), hydroxyacyl-CoA dehydrogenase (Spot 48) and 
aldehyde dehydrogenase (Spot 13), each is involved in oxidation of: the amino acid 
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leucine (Mohsen and Vockley, 1995),  lipids (Bajpai et al., 1998)  and aldehydes 
(Quintanilla et al., 2005), respectively. 
 
Oxidative phosphorylation components identified were various ATP synthase 
subunits (Spots 15, 18, 56 and 58), NADH dehydrogenase (Ubiquinone) flavoprotein 
2 (Spot 55) and both subunits of the electron transferring flavoprotein (Spots 37 and 
47). ATP synthase is the final stage of oxidative phosphorylation, and uses the proton 
gradient generated by the ETS to produce ATP (Garrett and Grisham, 1999). NADH 
dehydrogenase flavoprotein and the electron transferring flavoprotein transfer 
electrons to the ETS in order to generate the proton gradient mentioned above 
(Garrett and Grisham, 1999). The electron transferring flavoprotein is particularly 
important as it oxidises at least eleven matrix dehydrogenases, making it important 
link between fatty acid and amino acid oxidation and the ETS. So much so that 
defective copies of the protein results in metabolic disorders (Schiff et al., 2006). 
 
Creatine kinase (Spots 27 and 28) is used in ATP homeostatis, as it transfers a 
phosphate group from phosphocreatine stores. This is of particular importance in 
muscle mitochondria as it is used as a way of maintaining ATP levels in times of high 
energy consumption, such as muscle contraction (Bruton et al., 2003; Dahlstedt et al., 
2000). 
 
Proteins important in the maintenance of the mitochondria include: Glucose regulated 
protein 75 (GRP75) (Spot 1), hsp60 (Spots 7, 8 and 9), prohibitin (Spots 41 and 42), 
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SOD2 (Spots 52 and 53) and peroxiredoxin 3 (Spot 60). GRP75, hsp60 and prohibitin 
are all involved in facilitating the folding and assembly of proteins imported into the 
mitochondria (Nijtmans et al., 2000; Martinus et al, 1995; Mizzen et al., 1991). 
SOD2 and peroxiredoxin both detoxify ROS produced by the mitochondrial ETS. 
SOD2 reduces superoxide to hydrogen peroxide (Reddy and Beal, 2005) and 
peroxiredoxin reduces hydrogen peroxide to water (Chang et al., 2004). 
 
The presence of aldolase and enolase, considered to be cytoplasmic proteins, suggests 
a low level of cytoplasmic contamination of the mitochondrial preparation. However, 
these proteins have recently been shown to be present in or to interact with the 
mitochondria (Brandina et al., 2006; Giege et al., 2003). Apolipoprotein A-1 has 
been shown to interact with the beta subunit of ATP synthase (Martinez et al., 2003), 
and prohibitin is a protein which acts as a chaperone to stabilise newly synthesised 
proteins in the mitochondria (Nijtmans et al., 2000) and required in the mitochondria 
as most of the proteins are encoded by nuclear DNA (Paschen and Neupert, 2001). 
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CHAPTER SIX 
Final Discussion and Future Directions 
 
6.1 Final discussion 
 
This study used a global shot-gun approach to try and detect differences in the 
mitochondria from wild type and myostatin knockout muscle. A large muscle group 
with a mixed fibre type was used, so that there would be adequate sample and so that 
the changes to the fibre type switch, outlined in Chapter 1.2.1, would be apparent. 
Comparative proteomics was used, as it allows you to look at changes in protein 
expression levels without knowing what protein you are looking for. And a broad pH 
range was used in the IEF step so that a wide spectrum of mitochondrial proteins 
could be analysed. 
 
This resulted in six proteins being shown to be modulated in the knockout 
mitochondria. These proteins were unable to be identified by PMF due to the amount 
of protein present being too little to obtain an adequate spectrum. The majority of the 
proteins identified were high abundance mitochondrial proteins and showed no 
significant changes between the wild type and knockout mitochondria. 
 
Interestingly, two of the mitochondrial enzymes identified in this study have been 
reported to have decreased activity in glycolytic muscle mitochondria compared to 
mitochondria from oxidative fibres. Mogenson and Sahlin (2005) reported a two-fold 
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decrease in 3-hydroxyacyl-CoA dehydrogenase activity in EDL mitochondria 
compared to soleus mitochondria and Jackman and Willis (1996) have reported 
malate dehydrogenase to have a decreased activity in glycolytic fibre mitochondria. 
As the myostatin knockout mice serve as a model for glycolytic muscle metabolism 
due to their increased proportion of type IIB fibres (Girgengrath et al., 2005; Wegner 
et al., 2000). This suggests that the increased enzymatic activity observed by other 
researchers could be due to either enzyme activation in the oxidative fibre 
mitochondria or inhibition in the glycolytic fibre mitochondria, since the present 
study showed no significant change in the expression levels of these enzymes 
between wild type and myostatin knockout mitochondria. 
 
Proteomics studies analysing whole skeletal muscle samples from oxidative and 
glycolytic fibres have reported modulation of mitochondrial metabolic proteins 
between the fibre types. Aconitase, ATP synthase subunits, malate dehydrogenase, 
mitochondrial creatine kinase and NADH dehydrogenase were reported to be down-
regulated in the glycolytic fibres (Sayd et al., 2006; Donoghue et al., 2005; Okumura 
et al., 2005). Our study, using only mitochondrial samples isolated from the muscle, 
shows no significant change in expression of these proteins, suggesting the 
observations made by these researchers could be due to a decrease in mitochondrial 
density in these fibre types. This re-iterates observations made by other investigators 
that there is a decrease in the number of mitochondria present in glycolytic muscle 
fibres (Schmidt and Herpin, 1997; Jackman and Willis, 1996). 
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6.2 Future directions 
 
Having shown that spots 46, 49, 59, 63, 67 and 68 are being modulated at a level of 
significance greater than p<0.1, an effort should be made to try and identify these 
proteins. This would require loading more protein onto the 2-DE gel to bring the level 
of protein separated in the gel spot within the detection limits of MS based methods 
of identification (around 10ng of protein). This study has utilised MADLI-TOF MS 
and PMF to assign identity to protein spots, this however requires that the protein 
being identified already exist in a database. Analysing the samples by LC-MS/MS 
would give additional information and would be particularly useful if the proteins 
were unknown. Because the peptides are separated by LC, greater resolution of the 
peptides is achieved, and information is obtained on the lower mass peptides (below 
700Da) which are obscured by matrix peaks in MALDI-TOF MS. As described in 
Chapter 1.4.2, identification of unknown proteins can be facilitated by peptide 
sequencing performed using tandem MS. 
 
Having only detected 160 proteins in the 2-DE gels a more complete mitochondrial 
proteome could also be built up. To facilitate this, the resolution of the IEF step could 
be increased by using a narrower pH gradient, either focusing on one portion of the 
proteome or using a series of overlapping IPGs to build up a complete picture of the 
more hydrophilic proteins present. The protein loading could then be increased so that 
the lower intensity proteins can be detected with an appropriate protein stain. The 
increased resolution will allow for the proteins to resolve without overloading the 
gels. In order to resolve more high and low molecular weight proteins, gradient SDS-
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PAGE gels could be utilised for the second dimension. The increasing acrylamide 
concentration would limit the diffusion of lower mass proteins, and allow higher 
mass proteins to migrate further into the gel, than the continuous 12% SDS-PAGE 
gels which were used in this study. 
 
Two of the proteins which were identified during the study, 3-hydroxyacyl-CoA 
dehydrogenase and malate dehydrogenase, have been reported to have a decreased 
activity in mitochondria from glycolytic muscle, but were shown to be expressed at 
the same level during this study. This finding should first be confirmed by western 
blot analysis, using antibodies specific for these two enzymes. If no change in 
expression is occurring, the change in activity documented by Mogenson and Sahlin 
(2005) and Jackman and Willis (1996) could be because of a different isoform of the 
enzyme being expressed in mitochondria from the different fibre types, or some type 
of PTM of the enzyme.  
 
Protein isoforms are produced via differential mRNA splicing, and the proteins 
produced will quite often have different specificities or activities (Michael et al., 
1997). PTM of an enzyme can alter its activity, specificity, localisation and stability 
(Peck, 2005). Over 300 types of PTMs are known, the most common two being 
phosphorylation and glycosylation (Jenson, 2004). Different forms of various 
proteins were seen in this 2-DE experiment, including malate dehydrogenase, but no 
significant change in expression of these was detected. The different forms of 
proteins seen in 2-DE gels result from a change in net charge or molecular weight, 
this can be due to either differential mRNA splicing or PTM. 
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To determine how if the change in activity of the enzymes identified in this study 
were due to isoforms or PTM, the resolution of the IPG used would need to be 
increased to detect the different forms of the proteins being expressed in 
mitochondria from oxidative and glycolytic fibres. Specific PTMs, such as 
phosphorylation of a tyrosine residue, can be identified by western blot analysis. 
More specific information on where the PTM is located on the protein can be 
detected by MS, looking for differences in the mass of peptides generated by 
proteolytic digestion of the protein, and even the residue it is located on from peptide 
fragmentation information. 
 
Research comparing mitochondria from oxidative and glycolytic muscle fibres has 
pointed out two targets for further research into differences between the two 
subspecies of mitochondria, COX and the ANT. COX has consistently been shown to 
have decreased activity in mitochondria from glycolytic muscle fibres (Gueguen et 
al., 2005A; Gueguen et al., 2005B; Willis and Jackman, 1995), the reason for which 
is unknown. And glycolytic fibre mitochondria have been shown to have a higher 
affinity for ADP than oxidative fibre mitochondria, which is theorised to be because 
of differences in the ANT (Gueguen et al., 2005A; Gueguen et al., 2005B; Willis and 
Jackman, 1995). 
 
These targets are both membrane bound complexes and are thus highly hydrophobic 
and cannot be resolved by conventional 2-DE. Other methods for isolating membrane 
bound complexes of the mitochondria have been developed which separate out intact 
complexes, which are then subjected to further analysis by methods such as SDS-
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PAGE. Immuno-affinity techniques use antibodies specific for the complex of 
interest are conjugated to agarose beads, and are able to ‘fish out’ the complex from a 
mixture of mitochondrial proteins (Keeney et al., 2006; Schilling et al., 2005). 
Sucrose density gradient fractionation has been optimised to separate out the 
oxidative phosphorylation complexes from the mitochondrial membrane according to 
their mass (Hanson et al., 2001). Blue native gel electrophoresis separates out 
complexes under non-reducing conditions so the complexes remain intact. If this gel 
is rotated 90° and laid on a SDS-PAGE gel, it creates a 2-D map of the membrane 
bound components of the mitochondria (Brookes et al., 2002; Schagger and von 
Jagow 1991). Differences in the components of these complexes, detected by the 
analysis carried out after isolation could indicate functional differences in the 
complexes of mitochondria from glycolytic and oxidative fibres. 
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Appendix A 100µg of mitochondrial protein loaded onto 2-DE gel. 17cm 3-10NL 
IPG loaded with 100µg of mitochondrial protein from the knockout sample, second 
dimension run on a 12% SDS-PAGE gel, stained with silver stain plus MS 
compatible silver stain. 
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Appendix B 200µg of mitochondrial protein loaded onto 2-DE gel. 17cm 3-10NL 
IPG loaded with 200µg of mitochondrial protein from the knockout sample, second 
dimension run on a 12% SDS-PAGE gel, stained with silver stain plus MS 
compatible silver stain. 
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Appendix C 300µg of mitochondrial protein loaded onto 2-DE gel. 17cm 3-10NL 
IPG loaded with 300µg of mitochondrial protein from the knockout sample, second 
dimension run on a 12% SDS-PAGE gel, stained with silver stain plus MS 
compatible silver stain. 
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Appendix D Reproducibility of 2-DE gel protein loadings replicate number one. 
17cm 3-10NL IPG loaded with 220µg of mitochondrial protein from the knockout 
sample, second dimension run on a 12% SDS-PAGE gel, stained with silver stain 
plus MS compatible silver stain. 
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Appendix E Reproducibility of 2-DE gel protein loadings replicate number two. 
17cm 3-10NL IPG loaded with 220µg of mitochondrial protein from the knockout 
sample, second dimension run on a 12% SDS-PAGE gel, stained with silver stain 
plus MS compatible silver stain. 
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Appendix F Reproducibility of 2-DE gel protein loadings replicate number three. 
17cm 3-10NL IPG loaded with 220µg of mitochondrial protein from the knockout 
sample, second dimension run on a 12% SDS-PAGE gel, stained with silver stain 
plus MS compatible silver stain. 
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Appendix G Reproducibility of 2-DE gel protein loadings replicate number four. 
17cm 3-10NL IPG loaded with 220µg of mitochondrial protein from the knockout 
sample, second dimension run on a 12% SDS-PAGE gel, stained with silver stain 
plus MS compatible silver stain. 
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Appendix H Wild type replicate number one. 17cm 3-10NL IPG loaded with 220µg 
of mitochondrial protein from the wild type sample, second dimension run on a 12% 
SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. 
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Appendix I Wild type replicate number two. 17cm 3-10NL IPG loaded with 220µg 
of mitochondrial protein from the wild type sample, second dimension run on a 12% 
SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. 
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Appendix J Wild type replicate number three. 17cm 3-10NL IPG loaded with 220µg 
of mitochondrial protein from the wild type sample, second dimension run on a 12% 
SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. 
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Appendix K Knockout replicate number one. 17cm 3-10NL IPG loaded with 220µg 
of mitochondrial protein from the knockout sample, second dimension run on a 12% 
SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. 
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Appendix L Knockout replicate number two. 17cm 3-10NL IPG loaded with 220µg 
of mitochondrial protein from the knockout sample, second dimension run on a 12% 
SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. 
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Appendix M Knockout replicate number three. 17cm 3-10NL IPG loaded with 
220µg of mitochondrial protein from the knockout sample, second dimension run on 
a 12% SDS-PAGE gel, stained with silver stain plus MS compatible silver stain. 
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Appendix N Information on proteins identified from 2-DE gel spots. 
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